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Preface 
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In this thesis chapter 1 is a background on vitamin C, chapter 2 describes vitamin C transport and 
chapter 3 describes the effects of vitamin C in the brain followed by discussion and conclusion 
before the manuscripts are presented. 
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Manuscript I: Increased expression of vitamin C transporters in liver but not kidney and brain 
during deficiency 
 
Manuscript II: Chronic vitamin C deficiency promotes redox imbalance in the brain but does not 
alter sodium-dependent vitamin C transporter 2 expression  
 
Manuscript III: Prenatal vitamin C deficiency results in differential levels of oxidative stress during 
late gestation in foetal guinea pig brains 
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Sammendrag 
 
Vitamin C (VitC) er nødvendigt for flere fysiologiske funktioner og er centralt for normal udvikling 
af hjernen. I dette projekt har vi vist, at hjernen opretholder et VitC niveau på omkring 30 % af 
kontrolniveauet, mens andre organer udsættes for svær depletering under moderat og absolut 
mangel på VitC i kosten. Ratioen mellem VitC i plasma og cerebrospinalvæske var ens for alle 
fodringsgrupper. Den selektive tilbageholdelse af VitC i hjernen ved moderat og absolut mangel 
skyldtes ikke en overordnet regulering af SVCT2 ekspression. Det samme var tilfældet i de unge 
hjerner fra præ-/postnatal studiet, hvor der desuden blev påvist en øget andel af oxideret VitC og et 
højere niveau af lipid peroxidering ved VitC mangel. Fundene fra prænatal studiet viste, at føtale 
VitC niveauer var afhængige af det maternelle VitC indtag og at behovet for VitC i den føtale 
hjerne falder tæt på drægtighedens afslutning. Siden hjernens behov for VitC ikke var opfyldt under 
mangeltilstand er forøget superoxid dismutase (SOD) aktivitet sandsynligvis en beskyttende 
mekanisme. På trods af SOD kompensering var niveauet af lipid peroxidering øget i den føtale 
hjerne på begge undersøgte tidspunkter i den sene drægtighed. Selvom føtale hjerner med VitC 
mangel havde oxidativt stress, blev der ikke fundet signifikante forskelle mellem kontrolhjerner og 
hjerner med mangeltilstand for supplerende markører for oxidativ skade (hydroxynonenal- eller 
nitrotyrosin modificerede proteiner) eller for apoptose markøren caspase-3. I stedet blev der påvist 
forskel i ekspression for de målte markører mellem de undersøgte tidspunkter i den sene 
drægtighed. Samlet set viste vores data, at både hjernen under udvikling og den unge hjerne hos 
marsvin er prædisponeret for oxidativt stress som følge af subklinisk VitC mangel. 
Vores fund kunne have klinisk betydning hos mennesker, idet lavt maternelt indtag af VitC under 
graviditet kunne resultere i redox ubalance i den føtale hjerne og dermed muligvis have negative 
konsekvenser for hjernens udvikling hos børn af mødre med VitC mangel. Yderligere giver vores 
fund indsigt i betydningen af VitC for mindskelse af oxidativt stress medieret neurodegeneration.     
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Summary 
 
 
Vitamin C (VitC) is required for several physiological functions and is pivotal for normal 
development of the brain. In the current project we have shown that the brain sequesters about 30% 
of control VitC levels irrespective of differences in the VitC content in the diet while the other 
organs undergo severe depletion during deficiency and depletion. Ratio of VitC levels from plasma 
to cerebrospinal fluid (CSF) were the same in all dietary groups. This selective retention of VitC in 
the brain during deficiency or depletion was not by the mechanism of an overall regulation of 
SVCT2 expression. This data was supported by a similar finding in the pre/post natal VitC deficient 
brain which were shown to have increased percentage of oxidized VitC and lipid peroxidation 
levels. Our findings from low maternal VitC intake showed that foetal VitC levels are dependent on 
the maternal intake and that the demand for VitC in the foetal brain is higher at an earlier stage of 
the late gestation. Lack of meeting this demand of high VitC in the deficient brain displayed 
elevated superoxide dismutase (SOD) activity as a protective mechanism. However, lipid 
peroxidation levels were increased despite the compensation by SOD in the foetal brain at both 
investigated time points in late gestation. Although the VitC deficient foetal brains showed 
oxidative stress, none of the additional oxidative damage markers (hydroxynonenal or nitrotyrosine 
modified proteins) or the apoptotic marker (caspase-3) showed significant differences between VitC 
control and deficient brains. Instead, differential expression of the measured markers was detected 
during the late gestation. Our current data shows that both the developing brain and young brain of 
the guinea pig is predisposed to oxidative stress due to non-scorbutic VitC deficiency. 
 
We speculate that our findings may have clinical implications in humans due to low maternal VitC 
intake during pregnancy that may result in redox imbalance in the developing foetal brain or alter 
brain function in children born to VitC deficient mothers. In addition our findings give insight to the 
role of VitC in ameliorating oxidative stress mediated neurodegeneration. 
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Introduction 
 
Vitamin C (VitC) is an important micronutrient required for several important physiological 
functions [Mandl et al., 2009]. Prolonged low plasma VitC that may result in scurvy was once a 
devastating illness due to lesser access to fruits and vegetables [Harrison et al., 2010a]. Although 
reports on scurvy are rare in the western world marginal VitC deficiency (< 23µM in plasma) 
affects substantial population even in the developed parts of the world [Villalpando et al., 2003]. 
However, the effects of marginal VitC deficiency are unclear. 
 
VitC in the brain is considered one of the major antioxidants and was proposed to be vital for proper 
brain development. Brain VitC is several times greater than the plasma and most other organs and 
especially during deficiency brain is exceptional in maintaining high VitC concentration [Hughes et 
al., 1971]. Additionally, VitC repletion in the brain is rapid relative to repletion in the plasma 
suggesting a crucial requirement of high VitC levels in the brain [Tveden-Nyborg et al., 2012]. This 
finding indicates that the brain preferentially retains VitC. High levels of VitC in the brain are 
primarily achieved by the sodium dependent vitamin C transporter 2 (SVCT2) [Sotiriou et al., 
2002], that transports VitC from the choroid plexus into the cerebrospinal fluid (CSF), from where 
VitC enters into cells of the central nervous system (CNS) [Rice, 2000]. Lack of SVCT2 results in 
undetectable VitC levels in the brain leading to death soon/immediately after birth [Sotiriou et al., 
2002]. These results emphasize the vital role of SVCT2 in transporting VitC in the brain. In vitro 
studies have suggested an increased expression of the transporter, following decrease of 
intracellular VitC levels, to likely increase VitC uptake [Savini et al., 2007a; Savini et al., 2007b]. 
These findings suggest that the selective retention of high VitC in the brain during deficiency could 
be due to an adaptive mechanism of SVCT2 up-regulation to increase VitC uptake, leading to the 
hypothesis 1. Hence in the Manuscript I, the regulation of SVCT2 expression was investigated 
following VitC deficiency as well as depletion, together with analysis of VitC transport from 
plasma to the CSF.   
 
It has been shown previously that high levels of brain VitC are essential to provide protection from 
oxidative stress [Harrison et al., 2010a; Harrison et al., 2008]. Hence, increased VitC transport to 
the brain by an up-regulation of SVCT2 as suggested by in vitro studies [Savini et al., 2007b] may 
not alleviate oxidative stress in the brain during VitC deficiency, leading to the hypothesis 2. In our 
earlier study we have shown that prenatal non-scorbutic VitC deficiency results in hippocampal 
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volume reduction in the postnatal brain which was not improved despite repletion to control levels 
of VitC after birth [Tveden-Nyborg et al., 2012] suggesting that pre-natal VitC deficiency effects 
the brain and that the effect may be irreversible. Therefore we tested hypothesis 2 in Manuscript II 
by investigating the post natal effects of pre-natal VitC deficiency, on oxidative stress and SVCT2 
expression in the brain. We also assessed if postnatal repletion of VitC could reverse the effects of 
VitC deficiency in the brain.  
 
An earlier study by our group have shown that non-scorbutic VitC deficiency in the early postnatal 
life results in a 30% reduction in hippocampal neurons and impaired spatial memory [Tveden-
Nyborg et al., 2009]. In another study we have reported that cellular migration into the dentate 
gyrus granular layer of hippocampus was reduced in the prenatally deficient animals associating 
hippocampal impairment as an effect of VitC deficiency [Tveden-Nyborg et al., 2012]. These 
findings showed the effect of VitC deficiency in the brain at an early postnatal time or later and 
suggests that VitC deficiency due to low maternal intake of VitC may as well effect the pre-natal 
brain during gestation. The foetal brain is especially vulnerable due to rapid growth and immature 
antioxidant defence mechanisms [Lykkesfeldt et al., 2007]. Others have previously suggested that 
the foetal brain requires increase in VitC with progression in brain development [Harrison et al., 
2010b; Zalani et al., 1987]. The inability of meeting the requirement of high VitC due to maternal 
VitC deficiency imposes the foetus to oxidative stress leading to hypothesis 3. Hence we 
investigated the effect of pre-natal VitC deficiency on oxidative stress in the foetal brains at two 
gestational time points and the findings are presented in the manuscript III. 
 
Guinea pig is the animal model of our interest to investigate the effects of VitC deficiency because 
of its evolutionary loss of the functional gulono-g-lactone oxidase (Gulo) gene. As a result they 
cannot synthesize VitC endogenously and depend on the dietary intake similar to human beings 
[Nishikimi et al., 1992]. Moreover, guinea pig foetus has an extensive brain development during 
gestation, with the occurrence of brain growth spurt nearly two weeks before birth [Dobbing and 
Sands, 1970]. Also, we have previously established that 100mg/Kg diet in guinea pigs leads to a 
non-scorbutic VitC deficiency [Tveden‐Nyborg et al., 2012]. From the current work we expected to 
understand the role of Svct2 in sequestration of the brain VitC and the effect of non-scorbutic VitC 
deficiency on oxidative stress in the post natal and pre natal brain.  
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PhD hypotheses 
 
Hypothesis 1: High brain VitC relative to other organs is maintained in guinea pigs during 
deficiency through induction of sodium dependent vitamin C transporter, SVCT2. 
 
Hypothesis 2: Despite its preferential retention, non-scorbutic VitC deficiency increases oxidative 
stress in the brain of guinea pigs. 
 
Hypothesis 3: The guinea pig foetus is not protected from oxidative stress during maternal VitC 
deficiency. 
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Chapter 1 The biological function of Vitamin C 
 
 
VitC is an important micronutrient involved in several molecular pathways and is considered to be 
an effective antioxidant required to protect from oxidative stress and its mediated macromolecular 
modifications [Lykkesfeldt et al., 1997; Tveden-Nyborg and Lykkesfeldt, 2013]. Recent cross 
sectional studies based on plasma VitC levels have shown that a substantial population is VitC 
deficient (not the disease, scurvy) even in the developed countries [Villalpando et al., 2003]. 
However, the molecular effects of such non-scorbutic VitC deficiency are not clear. Guinea pigs, 
like humans are dependent on dietary VitC and serve as a valuable animal model to investigate the 
effects of VitC deficiency [Lykkesfeldt et al., 2007; Yu and Schellhorn, 2013]. 
 
1.1.1 Vitamin C in antioxidant functions 
 
VitC is well known for its ability to reduce other oxidizing compounds by donating electrons and 
thereby itself getting oxidized [Iyanagi et al., 1985; Linster and Van Schaftingen, 2007]. During this 
process VitC gets oxidized to ascorbyl radical (AR) following the loss of a single electron as shown 
in figure 1[Padayatty et al., 2003]. Dehydroascorbic acid (DHA) is formed after the loss of a second 
electron which is unstable at physiological pH and temperature [Padayatty et al., 2003]. Presence of 
different reductase enzymes permits the reversible reaction of AR or DHA to ascorbate anion 
(ASC), which is the predominant form of VitC that exists at normal physiological conditions 
[Kobayashi et al., 1991; Linster and Van Schaftingen, 2007].  
 
Biological functions of VitC can be specific and non-specific [Tveden-Nyborg and Lykkesfeldt, 
2013]. VitC is involved in specific functions as a co-factor in the stabilization of collagen which is a 
major protein required for maintenance of connective tissue and wound healing [Kim and 
Peterkofsky, 1997], in stabilization of peptide hormones which is central for the processing of 
hormonal peptides  in their active form [Murthy et al., 1987], in synthesis of carnitine that is needed 
for fatty acid transport into mitochondria for generating energy [Nelson et al., 1981], in 
norepinephrine synthesis which is an important catecholamine that regulates attention  [Levine et 
al., 1985], in tyrosine metabolism for the synthesis of dihydroxyphenylalanine (DOPA) which is a 
precursor of catecholamine synthesis [Levine et al., 1941], in regulation of HIF-1alpha which is a 
transcription factor that activates diverse cellular pathways for survival under low oxygen 
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conditions [Goda et al., 2003] and in the reduction of tetrahydrobiopterin which is necessary for the 
function of nitric oxide synthase to maintain endothelial cell functions [Yan et al., 2012]. VitC in all 
these functions donates electrons and keeps iron or copper involved in these enzymes, which are 
either monooxygenases that incorporate a single oxygen molecule or a dioxygenase that 
incorporates two oxygen molecules, in their reduced forms in order to keep the enzyme in the active 
state [Gropper and Smith, 2012; Padayatty et al., 2003]. 
 
The non-specific role of VitC includes its function as a scavenger of reactive oxidizing agents like 
hydroxyl radicals, superoxide, peroxynitrite etc. to maintain cellular redox status [Buettner, 1993; 
Rose and Bode, 1993]. VitC has also been shown to recycle oxidized alpha tocopheroxy radical and 
this synergistic action maintains integrity of the cellular membrane in the event of redox imbalance 
[Chan, 1993]. Hence VitC is considered vital for several cellular functions and to protect the cell 
from oxidative stress and its mediated effects. 
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1.1.2 Unchecked redox imbalance may modify macromolecules and cause 
apoptosis 
 
Biological systems are constantly exposed during aerobic metabolism to oxidants like free radicals 
that contain one or more unpaired electrons like superoxide anion (•O2-) , nitric oxide (NO•), 
hydroxyl radical (•OH) etc and oxidants that are not free radicals such as hydrogen peroxide (H2O2) 
[Finkel and Holbrook, 2000]. Some of the sources of biological oxidizing agents include 
mitochondria during aerobic respiration yielding •O2-, •OH and H2O2 due to electron leakage to 
oxygen from intermediate coenzymeQ instead of at cytochrome oxidase at complex IV [Halliwell, 
2006], neurotransmitter oxidation by monoamine oxidase, hypoxanthine oxidation during uric acid 
formation, fatty acid oxidation in the peroxisomes  [Sheu et al., 2006], NADPH oxidases in 
macrophages during host defence and clearance of cellular debris [Lambeth, 2004] etc. However an 
increased production of cellular oxidants has been linked to pathophysiological conditions [Sies, 
1997].To counteract the effects of oxidants biological systems are protected by antioxidant 
mechanisms and most commonly include endogenously available enzymes like superoxide 
dismutase (SOD) which can be cytoplasmic, mitochondrial or extracellular specific that generates 
H2O2 by dismutation of •O2- [Zelko et al., 2002], catalase (CAT) and glutathione peroxidase (GPx) 
that decomposes H2O2 to water [Michiels et al., 1994]. Additionally, presence of non-enzymatic 
antioxidants such as VitC, vitamin E and glutathione play a vital role in quenching the increased 
oxidizing agents as shown in the figure 2. [Valko et al., 2007]. The synergistic action of VitC and 
vitamin E have been shown to  result in an efficient inhibition of peroxidation [Niki et al., 1984; 
WEFERS and SIES, 1988].  
 
Impaired ability to maintain the redox status (Figure 2) can have several consequences on 
macromolecular modification and may result in tissue damage. Macromolecular oxidation can be 
enhanced by interaction within free radicals, for example •O2- with nitric oxide (NO•) forms 
peroxynitrite (ONOO–) and modifies proteins by nitration [Hurst, 2002]. Alternatively, the products 
accumulating from membrane oxidation can be the precursors of DNA or protein oxidation [Hartley 
et al., 1999; Marnett, 2002]. One of the extensively studied measures of oxidative stress is lipid 
peroxidation that could result due to formation of hydroxyl radicals (•OH) by Haber-Weiss reaction 
[Datta et al., 2000]. Lipid peroxidation is extensive in the presence of transition metals like ferrous 
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and cuprous ions [Halliwell and Chirico, 1993]. During the lipid peroxidation process, hydroxyl 
radical attack of the polyunsaturated fatty acids (PUFA) lets off a hydrogen atom from PUFA 
making it a lipid radical that can then react with oxygen to form lipid peroxyl radical and can 
readily attack another PUFA [Betteridge, 2000]. This reaction of forming lipid radicals can continue 
resulting in the disruption of membrane integrity that may alter the functional state of the cell 
[Betteridge, 2000]. Lipid peroxidation gives rise to by-products like malondialdehyde (MDA) and 
hydroxynonenal (HNE) that are highly reactive [Halliwell and Chirico, 1993; Hoff and O'Neil, 
1993] and can lead to further oxidation of macromolecules.  
  
Oxidative stress has been associated with activation of caspases in the apoptotic signalling 
[Ikonomidou and Kaindl, 2011; Rees and Inder, 2005], however, the underlying mechanisms are 
not clear. Caspase-3 that can be activated by several mechanisms has been shown to be 
indispensible during development [Jänicke et al., 1998]. Apoptosis is a complex mechanism with 
different initiation signalling factors involved in mediating the energy dependent pathway of events 
and activation of caspase-3 is where the different pathways may converge [Elmore, 2007]. Caspase-
3 activation results in DNA fragmentation and protein cross-linking during which several 
cytoskeletal and nuclear proteins are degraded and marked for phagocytosis [Schwartzman and 
CIDLOWSKI, 1993]. Both in vitro and in vivo studies have suggested the altered regulation of 
caspase-3 during different nutrient deficiencies [Bagnyukova et al., 2008; Cregan et al., 1999; 
Yamaguchi et al., 2001; Yen et al., 2002]. 
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1.1.3 Vitamin C deficiency and its prevalence  
 
Low levels of VitC for a prolonged period may lead to the clinical condition scurvy which is 
associated with fatigue, skin and dental abnormalities and impaired wound healing [Hirschmann 
and Raugi, 1999]. However scurvy is rarely seen even in the developing countries due to the access 
to VitC rich food sources [Hirschmann and Raugi, 1999] and since as little as 10 mg/day may 
prevent from the onset of this clinical condition [Jacob and Sotoudeh, 2002]. VitC deficiency has 
been classified based on VitC levels in the serum as severe (<11µM) and  marginal (11-23 µM) 
deficiency [Lykkesfeldt and Poulsen, 2010].   
 
Results from analysis of serum VitC from a population study of Mexican infants and children have 
shown above 25%  prevalence of both moderate and severe VitC deficiency [Villalpando et al., 
2003]. A cross-sectional study from the Canadian population suggested that out of seven young 
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adults three exhibit sub-optimal VitC levels which was further associated with increased expression 
of  markers related to chronic disease [Cahill et al., 2009]. A Brazilian cross-sectional study tried to 
establish relation between cord blood VitC and maternal characteristics and reported that cord blood 
VitC was associated to maternal VitC, VitC-rich food intake, per capita income and alcohol. VitC 
deficiency is especially prevalent in the people belonging to low socioeconomic groups which also 
reflects low VitC consumption during pregnancy to a greater extent in this subset of people 
[Oliveira et al., 2009]. These studies suggest a substantial prevalence of marginal VitC deficiency 
and a greater need to investigate the effects of low VitC.  
 
1.1.4.1 Guinea pig as an animal model of Vitamin C deficiency 
 
Guinea pigs like humans are exceptional species that lost the functional gene L-gulono-g-lactone 
oxidase (Gulo) during evolution [Nishikimi et al., 1992]. Therefore VitC cannot be synthesized in 
guinea pigs and must be supplied through diet as in the case of human beings [Nishikimi et al., 
1992]. This helps to successfully manipulate VitC dosage in guinea pigs to study the effects of non-
scorbutic VitC deficiency [Lykkesfeldt et al., 2007; Tveden‐Nyborg et al., 2012]. Guinea pigs also 
express GLUT1 on the erythrocytes similar to humans while rodents capable of synthesizing VitC 
express GLUT4 suggesting that since guinea pig and humans evolutionarily lost the functional Gulo 
gene, guinea pigs may mimic human  physiology more when investigating effects of VitC [Yu and 
Schellhorn, 2013].These animals were shown to be non-scorbutic when treated with precursor 
substrate of gulo together with modified Gulo enzyme suggesting that in addition to non-functional 
Gulo gene the endogenous substrate levels necessary for the modified gene is very low. However, 
this method of injecting the modified enzyme has been shown to have drastic effects [Hadley and 
Sato, 1989] which could mislead the primary focus of investigation. Hence dietary intervention has 
been the suitable way of assessing the effects of vital role of VitC on different aspects of physiology 
in guinea pigs [Bell et al., 2001; Heinrich et al., 2008; Lykkesfeldt and Moos, 2005]. 
 
1.1.4.2 Guinea pig foetal brain maturity during late gestation 
 
Guinea pigs have gestational length about 66 days with a rapid brain development termed as brain 
growth spurt occurring around gestational day 45 [Dobbing and Sands, 1970]. Therefore these 
animals serve as valuable models to assess the impact of nutritional deficiencies during brain 
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development in utero [Edwards, 1967; Suckow et al., 2011]. Some of the important events that take 
place during the early time points of the late gestation reflecting growth spurt in this species are 
maturation of neuronal nuclei, increase in dendrites, accumulation of Nissl substance and increase 
in enzymatic activity [Dobbing, 2008]. Guinea pigs are precocial and relatively mature at birth 
which is in agreement with the event of adult amount of DNA being achieved soon after birth. Since 
the increase of neurons to nearly adult numbers is reached before the multiplication of glial cells, 
the adult volume of neuronal nuclei in these species is achieved ~20 days before birth [Dobbing and 
Sands, 1970]. Hence deviation from normal development in the late gestation foetal brains may 
cause disruption in the neuronal development. 
 
In addition, Na+,K+- ATPase measured as an index of membrane function in developing brain of 
guinea pig foetuses at different gestational days resulted in a marked increase after GD45 and this 
increase was suggested to be coincidental to cholesterol content that peaks just before birth [Mishra 
and Delivoria-Papadopoulos, 1988b]. The authors suggested that increase of Na+K+- ATPase 
signifies a pre-natal functional maturation of membranes and that the enzyme activity is dependent 
on increase in cholesterol content, phospholipids and unsaturated fatty acids. Enzymatic activities of 
aerobic glycolytic metabolism were also shown to be increased ~15 days before birth and were 
similar to activity to the adult state which correlates well with pre-natal neurological competence 
[Booth et al., 1980]. Moreover, the enzymatic activities of antioxidants CAT, GPx, glutathione 
reductase and glucose 6-phosphate dehydrogenase that protect from redox imbalance were shown to 
be increased 15-20 days before birth [Mishra and Delivoria-Papadopoulos, 1988a] suggesting that 
guinea pig foetal brain is relatively mature in terms of combating oxidative stress during late 
gestation. These findings suggest that the developmental pattern in guinea pig differs from humans, 
by being relatively mature and precocial at birth, but is a better animal model than other common 
rodent models. However, to target the peak of neurogenesis period, VitC deficiency must be 
imposed during gestation in guinea pigs.  
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Chapter 2  Vitamin C transport  
 
 
Both ASC and DHA are reported to be absorbed by enterocytes of the human intestine [Malo and 
Wilson, 2000]. Since Asc exists as an anion at physiological pH and as DHA is relatively less 
hydrophobic, neither of the VitC forms can directly pass through the cellular membranes. To a 
small extent VitC was suggested to cross the cell membrane through passive diffusion however, this 
mechanism of transport is of minor importance [Lindblad et al., 2013]. Hence the primary transport 
of VitC relies on the transporters in the cell membranes as discussed in the sections below. The 
efflux of VitC from intestinal cells to the blood is vital to reach target tissues but the mechanism is 
not clear [Wilson, 2005]. It was proposed that volume sensitive anion channels in the intestinal 
epithelial cells may contribute for ASC efflux into ECF from where ASC may enter blood plasma 
through discontinuities in the capillaries [Liang et al., 2001]. Findings from ASC transport in 
endothelial cells proposed trans-endothelial movement or para-cellular movement of ASC as a route 
to reach tissue interstitium [May and Qu, 2009; May et al., 2009]. ASC from blood circulation upon 
reaching the kidney is filtered by the glomerulus and most of the VitC is then reabsorbed in the 
proximal tubules which is crucial for maintaining VitC levels in the body [Wilson, 2005]. 
 
2.1.1 DHA transport 
 
DHA transport occurs by facilitative diffusion through glucose transporters (GLUT) and the 
mechanism is Na+ independent [Liang et al., 2001]. Differential distribution of the facilitative 
glucose transporters GLUT1, GLUT3 and GLUT4 enable uptake of DHA across a concentration 
gradient into the cells followed by rapid reduction of DHA into ASC [Rumsey et al., 2000; Rumsey 
et al., 1997]. Most of the blood cells were reported to transport DHA by this mechanism with VitC 
in its reduced form trapped intracellularly [Agus et al., 1997]. Due to this reduction mechanism , 
low levels of DHA are maintained in the cells which generates a concentration gradient across the 
plasma membrane and favours DHA uptake into the cells [Wilson, 2005]. A study with human 
intestinal brush border vesicles from different parts of the intestines showed that DHA is absorbed 
through the entire small intestine. However, the affinity with which DHA is transported is much 
lower (Km in enterocytes ;0.8 mM) indicating that most of VitC absorption is in its reduced form 
[Malo and Wilson, 2000]. Since DHA concentrations are drastically lower than ASC (95% human 
plasma) under normal physiological conditions, GLUT mediated DHA transport is unlikely to be 
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sufficient to meet cellular needs [Liang et al., 2001].  Additionally, DHA uptake competes for 
GLUTs with glucose which is 1000-fold higher  than the levels of DHA (Wilson 2002)  suggesting 
that DHA transport under normal physiological conditions is a very minor contributor to total VitC 
homeostasis [Rumsey et al., 1997].  
 
2.1.2  ASC transport 
 
 Two membrane isoforms were characterized for the transport of ASC, sodium dependent vitamin C 
transporter1 (SVCT1) and SVCT2 [Tsukaguchi et al., 1999].  The SVCTs transport L-asorbate with 
a Na+: Asc stoichiometry ratio of 2:1, against a concentration gradient by active transport and 
achieve high intracellular levels [Godoy et al., 2007; Harrison and May, 2009]. Energy for the 
transport is dependent on Na+/K+-ATPase and in-vitro studies have shown that incubation of cells 
with an inhibitor of Na+/K+-ATPase completely abolishes ASC transport [Savini et al., 2008]. Other 
ions tested in place of Na+ have also been shown to abolish uptake of  VitC and decreased the 
transporters’ binding affinity at a lower pH [Liang et al., 2001]. The amino acids sequence 
homology between human SVCT1 and SVCT2 is nearly 65% with altogether 12 transmembrane 
domains but do not share a similar homology with other sodium co-transporters [Tsukaguchi et al., 
1999]. However, the two transporters differ in the mechanism by which they transport VitC based 
on their distribution in cells and by varying in the affinity and capacity with which they transport 
VitC [Rivas et al., 2008]. Cellular studies on intestinal epithelial cells and  kidney proximal tubule 
cells have reported polar localization of the transporters with the presence of SVCT1 on the apical 
side and SVCT2 on the basolateral side [Boyer et al., 2005; Nualart et al., 2013; Savini et al., 2008] 
suggesting that both transporters are required for effective VitC transport in these cells. Boyer et al., 
suggested that SVCT1 on the luminal or apical side contributes to VitC absorption and SVCT2 on 
the basolateral side involves in uptake of VitC from the blood to the intestinal cells [Boyer et al., 
2005] indicating non-redundant functions of the transporters.  
 
2.1.3 Physiological roles of SVCT1 
 
SVCT1 is a high capacity/low affinity transporter (Km 65–252 μM) and  transports more VitC than 
needed to maintain homeostasis in the body [Corti et al., 2010; Lindblad et al., 2013; Wilson, 
2005]. SVCT1 is predominant in kidney, liver and intestine and plays a vital role in reabsorption 
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and regulation of vitamin C levels in plasma. This was supported by a study involved with  SVCT1 
encoding gene knockout, Slc23a1–/– , mice which were shown to have increased urinary loss of VitC 
due to the failure of kidneys to reabsorb VitC, resulting in significantly lower VitC levels in the 
plasma [Corpe et al., 2010].  In the same study VitC levels in the brain and adrenal was not effected 
suggesting retention of VitC by tissues predominant with SVCT2 distribution while other organs 
tested showed decrease in tissue VitC levels in the Slc23a1–/– mice. SVCT1 expression in the apical 
membrane of proximal tubules of the kidney was reported to increase progressively in the 
developing postnatal mice suggesting that  VitC reabsorption after birth is enhanced by an increased 
SVCT1 expression in the proximal tubules [Nualart et al., 2013]. Liang et al proposed that protein 
kinases effect the intracellular transport of VitC by increased removal of the transporter from the 
membrane or decreased membrane insertion of the transporter in an in vitro study [Liang et al., 
2002] indicating that cellular metabolism may influence the function of SVCT1.  
 
2.1.4 Physiological roles of SVCT2 
 
SVCT2 is a low capacity/high affinity transporter (Km 8–69 μM) that enables efficient 
concentration of VitC by widespread uptake [Rivas et al., 2008; Savini et al., 2008]. SVCT2 has 
been detected in most tissues [Liang et al., 2001] and is vital for maternal transport of VitC to the 
foetus and VitC accumulation in the CNS [Sotiriou et al., 2002]. In-vitro studies on human 
trophoblasts and the first trimester chorionic villi were reported to express SVCT2  which is 
important for the transfer of maternal VitC to the foetus [Biondi et al., 2007]. SVCT2 expression 
has been suggested to protect from oxidative stress due to its vital role in the uptake of VitC in 
metabolically active tissues and specialized cells [Savini et al., 2008]. SVCT2 protein has several 
cysteines that may be susceptible to protein oxidation when there is an increase in the cellular 
oxidants [May, 2012]. An in-vitro study reported oxidative modification of sulfhydryl groups on 
SVCT2 following exposure with oxidizing agents [May and Qu, 2004]. Additionally, SVCT2 also 
has sites for the binding of activating protein-1 (AP-1) and nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-kB)  transcription factors that are involved in transcription of 
redox sensitive genes [Savini et al., 2007b] suggesting that its regulation may be based on the redox 
status of the cellular environment. Two in vivo studies on ischemia have reported redox regulation 
of SVCT2  [Berger et al., 2003; Gess et al., 2011]. Both the studies have shown an increase of 
SVCT2 around the affected areas suggesting that elevated stress could up-regulate SVCT2 in the 
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brain as a compensatory mechanism. SVCT2 protein expression in the rat brain showed high levels 
of the transporter in cornu ammonis (CA) and dentate regions of the hippocampus as well as 
cerebral cortex which  is in accordance with the analysed VitC levels, suggesting that the expression 
of this transporter may be prominent in the regions where antioxidants levels are present in high 
levels [Mun et al., 2006]. Deletion of gene encoding SVCT2 has been shown to result in 
undetectable levels of VitC in the brain and intra-cerebral haemorrhage leading to perinatal death 
[Sotiriou et al., 2002]. These findings show that SVCT2 is indispensable for VitC transport. 
 
2.1.5 Transport of VitC in the brain 
 
Since SVCT1 is not expressed in the CNS, SVCT2 is the critical transporter involved in VitC 
uptake in the brain [Berger and Hediger, 2000; Lee et al., 2003]. Tight junctions between 
endothelial cells of the blood brain barrier and the lack of SVCT2 in brain capillary endothelial cells 
makes VitC entry primarily thorough the choroid plexus epithelial cells where high levels of 
SVCT2 have been reported [Harrison and May, 2009].VitC from the plasma is transported into the 
CNS by generating concentration gradients in two steps as shown in figure 3. The first 
concentration gradient is generated upon active transport of VitC by SVCT2 across choroid plexus 
epithelial cells [Rice, 2000; Spector and Lorenzo, 1973]. From the choroid plexus, ASC is 
transported to CSF where the levels of VitC are reached around the same as in ECF by diffusion. 
Transport of ASC from ECF  into neurons is also mainly by SVCT2 that generates another sharp 
concentration gradient in the neurons by accumulating several fold higher intracellular VitC 
levels[Grünewald, 1993; Sotiriou et al., 2002].  
 
 Conversely glial cells have been reported to lack either of the SVCT transporters [Berger and 
Hediger, 2000]. However, DHA generated in the neurons leaves through GLUTs to the ECF and 
enters the glial cells which comprise GLUTs in their membranes [Harrison and May, 2009]. DHA is 
rapidly reduced to ASC in the glial cells and thus accumulated intracellular ASC can be released 
back into ECF by an unknown mechanism. DHA is toxic to the neurons in the absence of its 
clearance by the glial cells   [Wilson, 2005]. DHA can also be transported directly through the 
GLUTs present in the blood brain barrier but due to its very low levels detected in the blood this 
mechanism of transport  may be of little significance [Liang et al., 2001]. 
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2.1.6 Modulation of VitC transport 
 
Reports from in vitro studies suggested that intracellular signalling may effect VitC transport. In 
human hepatic cell line SVCT1 was shown to be decreased by  protein kinase C signalling and 
phosphorylation events resulting in down regulation of VitC uptake [Reidling et al., 2008]. 
Similarly increase in Svct2 mRNA by glucocorticoids resulted in an increased VitC uptake [Fujita et 
al., 2001]. VitC uptake in intestinal cells derived from the hypervitaminosis guinea pigs was shown 
to be significantly reduced compared to the control group  suggesting that VitC transport is effected 
by intracellular VitC levels [Karasov et al., 1991].  Depletion or repletion of VitC in the  in-vitro 
studies showed modulation of VitC transport, with depletion of VitC resulting in an increased 
expression of the SVCT2 in the platelets and conversely addition of VitC levels resulting in a 
decreased SVCT1expression in the intestinal cell line [MacDonald et al., 2002; Savini et al., 
2007a]. Among the in-vivo studies, depletion of VitC in the smp30/gnl−/− mice that cannot 
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synthesize VitC resulted in an increased mRNA of both SVCTs in the liver. The results reflected 
increased VitC uptake in the hepatocytes of these mice [Amano et al., 2010]. These findings suggest 
that intracellular VitC levels may regulate the transporters in vivo too. We have also shown SVCT1 
up-regulation in the VitC deficient liver and an up-regulation of Svct2 in the VitC depleted liver of 
the guinea pigs (Manuscript I- Figure 2). Based on this finding we suggested that SVCT1 may 
increase during chronic deficiency and SVCT2 may increase during severe deficiency of VitC. In 
contrast, our results from non-scorbutic VitC deficiency or depletion or repletion of VitC in guinea 
pigs reflected VitC levels in the brain (Manuscript I- Table 2 ; Manuscript II- Table 2) but did not 
show significant changes in the SVCT2 expression (Manuscript I – data not shown; Manuscript II- 
Figure1 & 3). Our findings suggest that low VitC levels in the brain may not regulate the overall 
SVCT2 expression in the brain and is in accordance with SVCT2 expression  reported by others in 
VitC deficient gulo-/- and smp30/gnl−/− mice brain [Amano et al., 2010; Meredith et al., 2011].  
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Chapter 3 Roles of Vitamin C in the brain 
 
3.1.1 VitC levels are differential in the brain 
 
VitC in the brain has been shown to be several-fold higher than plasma indicating that  high levels 
may be essential for proper functioning of the CNS [Harrison and May, 2009]. An earlier study in 
the guinea pig brains has reported nearly similar levels of VitC in the forebrain, midbrain and the 
hindbrain regions [Chinoy, 1972] and later it was suggested by Mefford et al that heterogenous 
VitC levels in the brain are possibly due to the differences in neuronal innervations [Mefford et al., 
1981]. In agreement high VitC levels were reported in the developing brain cortex of the new born 
rat during which time point neuronal cells are considerably higher compared to glial cells, 
suggesting preferential VitC localization in the brain to be a characteristic of neurons [Rice and 
Russo-Menna, 1997]. Hippocampus, the brain region associated with memory and spatial 
navigation was reported to have high VitC levels in the human, rat and the mouse brain [Harrison et 
al., 2010b; Mefford et al., 1981; Milby et al., 1982]. Along with the hippocampus, high VitC levels 
were reported  in the cerebellum, olfactory bulbs and the frontal cortex and conversely low levels of 
VitC were reported from pons and spinal cord  [Harrison et al., 2010b]. We have also shown 
differential VitC levels in the cerebellum and brain cortex of the guinea pigs (Manuscript I- Table 
2). High levels of VitC in the cortex than cerebellum in our finding may be due to the differences in 
neuronal density in the analysed regions. These findings suggest that the role of VitC in the brain 
may be complex in-part due to differential levels within the brain.   
 
3.1.2 Preferential retention of VitC in the brain  
 
A consistent finding from VitC depleted guinea pigs and mice is that brain retains approximately 
25% of VitC while the other organs are severely depleted underlining its preferential retention in 
the brain [Harrison et al., 2010b; Harrison and May, 2009; Hughes et al., 1971]. In accordance, our 
results show that non-scorbutic VitC deficient brain retains at least 30% of control VitC levels 
while kidney and liver showed 15-20% of control VitC levels (Manuscript I- Table 2). Moreover, 
VitC depletion resulted in drastically low retention of VitC in the kidney and liver with less than 
2% of control levels while the brain retained 30% of control levels (Manuscript I- Table 2). Most 
importantly the depleted group had begun to loose body weight which is one of the early signs of 
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scurvy (Manuscript I- Figure 1) and yet the brain retained relatively high VitC levels. We showed 
similar VitC retention in foetal guinea pig brains at two time points of late gestation, pre-term/GD 
45 and near-term/GD 56), due to low maternal VitC intake. (Manuscript III- Table 2). Also, the 
developmental decline of brain VitC at near-term as seen in the control group was not detected in 
the near-term deficient group signifying the requirement of maintaining optimum VitC levels during 
development. Hence, despite the preferential retention of VitC in the brain, non-scorbutic VitC 
deficiency or low maternal VitC intake may not be sufficient to tolerate the free radical mediated 
reactions that are suggested to be high in highly metabolic tissues like brain, and may lead to 
oxidative stress.   
 
3.1.3.1 Low VitC intake imposes oxidative stress 
 
We have previously shown that VitC deficiency in weanling guinea pigs significantly increased 
brain MDA levels compared to VitC sufficient controls [Lykkesfeldt et al., 2007]. Similar results 
were reported by others in VitC deficient Gulo-/- mice, with elevated neuroprostane levels in both 
cortex and cerebellum compared to Gulo+/+ mice [Harrison et al., 2008]. The same authors 
demonstrated higher lipid peroxidation and a marked decrease of type IV collagen colocalization 
with laminin in SVCT2 -/- foetal cortex. However, immunohistochemistry revealed strong staining 
for type IV collagen in the endodermal membrane [Harrison et al., 2010a] and the authors suggested 
that unhydroxylated type IV pro collagen is retained due to defect in collagen secretion in the 
SVCT2-/- brains that may have led to capillary haemorrhage. Additionally isoketal staining, another 
lipid peroxidation marker, and apoptotic cells were also reported to be high in the SVCT2-/- brain 
[Harrison et al., 2010a].  
 
Our results also showed an increase in lipid peroxidation marker, MDA, due to pre/post natal VitC 
deficiency (Manuscript II- Table 2) and in the late gestational foetal brains due to low intake of 
maternal VitC (Manuscript III- Figure 1B). In contrast, our results did not show significant changes 
in other analysed protein oxidation markers (Manuscript III- Figure 1A, 1C) or apoptotic marker 
caspase-3 (Manuscript III- Figure 2), between VitC control and deficient groups suggesting 
differential regulation of oxidative stress markers during development. In addition, SOD activity 
was increased in the VitC deficient foetal brain at both time points suggesting increase in the 
superoxide anion. Increased SOD activity together with elevated MDA levels suggests that 
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oxidative stress caused by non-scorbutic VitC deficiency may not be alleviated by compensatory 
mechanisms. Therefore, high levels of brain VitC are essential to protect from oxidative stress. 
Main findings from studies by others on the role of VitC, in protecting against oxidative stress 
induced by hypoxia, alcohol and neurotoxic compounds are discussed in the following sections to 
support the protective role of VitC. Based on our results and findings by others the effect of low 
VitC levels is graphically represented in figure 4. 
 
 
 
 
3.1.3.2 Effect of VitC on hypoxia mediated oxidative stress 
 
Role of VitC as one of the major antioxidants in the brain is supported by a study in pond turtles 
that have higher levels of VitC than rats and have a higher tolerance to hypoxia and the 
reoxygenation suggesting that high VitC levels compensate to prevent oxidative damage [Rice et 
al., 2002]. Lipid peroxidation markers in these species showed to be minimal during hypoxia or 
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reoxygenation compared to damage reported due to hypoxia or recovery in mammals [Willmore 
and Storey, 1997]. VitC was shown to sharply rise in the voltammetric measurements from rat 
hippocampus when hypoxia was induced suggesting VitC as vital free radical scavenger [Cammack 
et al., 1992]. In a primate animal model the effect of pre-treatment of VitC on middle cerebral artery 
occlusion (MCAO) was shown to decrease the infarct sizes significantly smaller, suggesting that 
VitC has a potential role  in reducing infarction [Ranjan et al., 1993]. Similarly, intraperitoneal 
injection of VitC (500mg/Kg) in gerbils1 before and  after bilateral carotid artery occlusion 
(BCAO) reduced neuronal damage modestly in hippocampus and significantly in striatum as 
assessed by histology [Stamford et al., 1999]. Another in-vivo study by Miura et al demonstrated  
neuroprotective effect of VitC following cerebral ischemia in rat pups by showing fewer fodrin 
break down products that signifies suppression of calpain activation resulting in lesser necrosis and 
damage  [Miura et al., 2006]. In a later study in rat pups intraperitoneal injection of VitC (750 
mg/Kg) before and after hypoxia significantly decreased macroscopic brain injury, decreased both 
necrotic and apoptotic cells in the different regions of the brain including  hippocampus, suggesting 
that neuroprotective role of VitC partly includes inhibition of caspase-3 and calpain activation 
[Miura et al., 2009]. As mitochondria are the major sources of free radical production, transient 
ischemia was proposed to result in disruption of mitochondrial function and VitC treatment in dams 
before intrauterine ischemia was reported improve mitochondrial respiratory function in the foetal 
brain homogenates [Nakai et al., 2002]. Under normal conditions hypoxia inducible factor (HIF)-
1alpha is hydroxylated by a prolyl-hydroxylase with VitC as a co-factor resulting in hydroxylated 
HIF-1alpha which is targeted to proteosomal degradation to control the regulation of HIF targeted 
pathways [Wenger et al., 2005]. Results from an in-vitro study showed that low VitC negatively 
affects prolyl hydroxylases by which increased stabilization of HIF-alpha can occur with the result 
of transcriptional activation of several target genes involved in glycolysis, cell survival etc. [Nytko 
et al., 2007]. However, a similar mechanism of VitC in vivo is not known.  
 
3.1.3.3 Effect of VitC on ethanol induced oxidative stress 
 
Voltammetry experiments in the rat brain demonstrated a dose dependent rise in VitC levels in the 
ECF in nucleus accumbens and striatum by intraperitoneal injections of ethanol [Svensson et al., 
1992] suggesting that brain VitC levels can be effected by ethanol. Increased lipid peroxidation was 
reported in the rat cerebellum that was accompanied by significant decrease in VitC levels 
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following an intraperitoneal administration of ethanol [Rouach et al., 1987] suggesting that VitC is 
consumed in the process of free radical scavenging.  Consumption of alcohol during pregnancy has 
been shown to result in foetal alcohol syndrome that affects the brain of the foetus by marked 
reduction in size (microencephaly) and retardation of growth and studies supporting this hypothesis 
have shown that excessive alcohol induces neurodegeneration accompanied by formation of free 
radicals [Haorah et al., 2005]. The protective effect of VitC was demonstrated by a reported 
reduction in ethanol induced microencephaly and growth retardation in the embryos treated with 
VitC before or concurrently with ethanol [Peng et al., 2005]. The forebrain size in this study was 
restored to near-control values when pre-treated with VitC and histological assessment reported 
nearly 50 % of neurons to be abnormally large when untreated with VitC. VitC pre-treatment 
suppressed H2O2, MDA, transcription levels of NF-kB and restored neural markers as a protective 
mechanism [Peng et al., 2005]. In another study, SOD and catalase activities were elevated as a 
protective mechanism in the VitC treated guinea pig brain,  suggesting modulation of endogenous 
antioxidants by VitC to reduce ethanol effects [Suresh et al., 1999]. 
 
3.1.3.4 Effect of VitC on oxidative stress induced by toxic compounds 
 
Toxic effects of 1-methyl-4-phenyl pyridinium ion which was mainly promoted by depletion of 
dopamine and degeneration of striatal neurons by promoting lipid peroxidation was shown to be 
significantly reduced by intraperitoneal administration of VitC before the administration of the 
toxin  [Wagner et al., 1986]. Similarly neurotoxicity caused by 3,4-ethylenedioxymethamphetamine 
(MDMA) has been shown to increase free radical mediated decrease in tissue 5-HT (5-
hydroxytryptamine or seretonin) which was shown to be prevented by concomitant injections with 
VitC in the rat striatum [Shankaran et al., 2001].  A recent study in rats have shown that VitC 
administration after MDMA treatment downregulates GFAP expression and limited the reduction of 
ATP and 5-HT [Li et al., 2006]. May et al showed that one of the ways that VitC protects from 
neurotoxicity at least in part is by sparing alpha tocopherol and decreasing lipid peroxidation in the 
neuronal cells [Li et al., 2003]. The effects of VitC against toxic compounds in the brain was also 
shown by restoration of acetyl cholinesterase activity which is vital in the regulation of cholinergic 
synapses [Ambali et al., 2010], in preserving normal morphology of the neurons [El-Hossary et al., 
2009], and by increasing endogenous antioxidants like SOD, CAT, GPx and glutathione reductase 
[Muthuvel et al., 2006]. Additionally, neuroprotective effect of VitC against toxic compounds was 
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associated with increased expression of anti-apoptotic genes that may enhance cell viability 
[Venkataraman et al., 2007].  
 
3.1.4 Markers in neuronal cells development and maturation 
 
Cellular development in CNS involves  progression of cellular events like proliferation, 
differentiation, migration and maturation in order to determine the fate of the neuron and its 
location to interact with other neuronal circuits [Meller and Tetzlaff, 1975]. Differentiation of the 
CNS precursors can give rise to neurons and glial cells [Temple, 2001]. Differentiated neuronal 
lineage cells express doublecortin (DCX) and polysialylated embryonic form of the neural cell 
adhesion molecule (PSA-NCAM) and are referred to as immature neurons [und Halbach, 2007]. 
Immature neurons move from the midst of proliferative and differentiated cells and this stage aids 
in neuronal migration and DCX is the most popular marker of interest at this stage [Gleeson et al., 
1999]. A study from neuronal cultures of dentate gyrus origin has shown that DCX supports the 
dendrites in elongation and reduced expression of DCX reduces dendritic motile structures called 
filopodia [Cohen et al., 2007]. Migrating neurons mature by extension of dendritic and axonal 
processes and this filopodia enhanced movement enables them to reach destined locations to make 
synaptic connections with other neuronal processes [Rakic, 1990]. The molecular mechanism of 
neuronal migration involves organization of cytoskeletal proteins with microtubule associated 
proteins (MAPs) like DCX leading to polymerization and stabilization of microtubules and actin 
filaments for proper orientation of the dendritic processes and filopodia [Feng and Walsh, 2001]. 
During this process a complex range of events ensure phosphorylation of MAPs and regulation of 
kinases like cyclin dependent kinase 5 (Cdk5) by regulator proteins such as P35 [Chae et al., 1997; 
Tanaka et al., 2004] and (brain1) Brn1 [Sugitani et al., 2002] to prepare the new neurons to correct 
locations as dictated by extracellular signalling cues [Ayala et al., 2007]. Finally, expression of 
neuron specific neuclear protein (NeuN) by the post mitotic neurons signifies maturation of neurons 
[Sarnat et al., 1998].  VitC effects on cellular events has been summarized in figure 5 based on 
results from the studies discussed in the following sections. 
3.1.4.1 Effect of VitC on proliferation 
 
Analysis of the stage specific markers by incorporation of synthetic nucleotide analogs during cell 
division like bromodeoxyuridine (BrdU) and analysis of stage specific markers has been popular 
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methods to investigate cellular development in the CNS [Ming and Song, 2005]. The CNS 
precursor cells divide and express their phenotype specific markers like nestin and glial fibriallry 
acidic protein (GFAP) together with endogenous cell division markers [Christie and Cameron, 
2006]. Administration of consecutive BrdU injections to neonatal guinea pigs from P5-P9 that were 
assigned to VitC sufficient, deficient, repletion and depletion groups and assessment of proliferation 
and survival of the BrdU positive cells in hippocampus showed no significant differences [Tveden-
Nyborg et al., 2012]. These results suggest that prenatal VitC deficiency does not affect postnatal 
newborn cells in the hippocampus. The results of Tveden-Nyborg et al were in line with an in vitro 
study which investigated effects of VitC in CNS precursor cells isolated from embryonic cortex of 
rat brain that showed no differences in proliferation in the cells treated with or without VitC [Lee et 
al., 2003]. In another study, significant inhibitory effect of VitC was seen on proliferation of 
astrocytes that were cultured from new born rat [Cheng et al., 1988] while the opposite effect was 
observed  for VitC in rat embryonic mesencephalic cultures which showed a marked increase of 
GFAP [Kalir and Mytilineou, 1991]. These contrasting results were suggested to have been due to 
difference in the source of the tissue, being embryonic or neonatal brain tissue, employed in the 
studies [Kalir and Mytilineou, 1991]. Therefore due to limited reports, effect of VitC on 
proliferation in CNS remains inconclusive. 
 
3.1.4.2 Effect of VitC on differentiation and maturation 
 
Our earlier VitC dietary intervention study has shown a negative effect of VitC on migration of new 
born cells into the granular layer of hippocampal dentate gyrus [Tveden-Nyborg et al., 2012]. 
Analysis of  the percentage of BRDU positive cells in sub-regions of the dentate gyrus  in the 
prenatally VitC deficient guinea pig brains, showed significantly lower number of cells in the 
granule layer and significantly higher in the subgranular layer, compared to controls with sufficient 
VitC. Our preliminary results from mRNA expression analysis of neuronal migration markers brn1, 
p35, cdk5, dcx from VitC control, deficient and repleted  hippocampus of guinea pigs did not show 
significant differences (data not published) indicating  that the observed delayed migration is 
complex to be detected by mRNA analysis.  
 
VitC has been shown to enhance neuronal differentiation from  mouse embryonic stem cells and the 
differentiated  neurons in presence of VitC in the culture media had  increased  neurons that were 
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positive for Tyrosine hydroxylase (TH), the enzyme responsible for the formation of the precursor 
of dopamine [Lee et al., 2000]. Consistently with the increase of TH positive neurons, dopamine 
levels were also increased in the media that had VitC and further analysis determined these neurons 
as functional [Lee et al., 2000]. Another study performed in embryonic rat mesencephalic cell 
cultures also showed a similar finding that addition of VitC in the medium significantly increases 
TH positive neurons compared to the cultures without VitC. This study additionally showed that 
VitC also increases serotonergic neurons and the authors suggest that VitC may activate cell 
differentiation that effects dopaminergic neuronal yield [Yan et al., 2001]. Yu et al showed that 
VitC treated CNS precursor cells derived from rat embryonic mesencephalon had increased 
expression of neuronal (MAP2a and MAP2b) and astrocytes (GFAP) markers indicating that VitC 
stimulates formation of both neurons and astrocytes [Yu et al., 2004]. In this study, the yield of 
dopaminergic neurons was very low when untreated with VitC. In contrast, when VitC was added 
to the medium during proliferative or differentiation phases of the cells, increase in TH positive 
neurons was markedly significant. This study confirmed up- regulation of tyrosine hydroxylase by 
both gene and protein expression, in response to VitC treatment in the cells, suggesting 
transcriptional and translational effect of VitC on dopaminergic neuronal differentiation [Yu et al., 
2004]. However, the up-regulated molecular markers identified by cDNA micro array analysis were 
different from the markers that were known to play an important role in the midbrain and the 
authors suggested that VitC may promote dopaminergic neuronal differentiation by uncharacterized 
pathways [Yu et al., 2004]. Similarly, VitC treated CNS precursor cells from rat embryonic cortex 
showed enhanced effect of VitC on differentiation to neurons and astrocytes as measured by 
neuronal Tuj1and astrocytic GFAP positive cells and morphology of the VitC treated cells were 
more mature with longer extended processes [Lee et al., 2003]. Additionally, Lee et al gave insights 
on the molecular mechanisms involved in the process of VitC enhanced differentiation by 
investigating mRNA expression of some of the known genes vital to differentiation into neurons 
and astrocytes. Their results showed that presence of VitC in the cultures increased four out of 
twenty genes investigated. Among them are NeuroD and Notch, markers involved specifically in 
neuronal and astrocytes differentiation, respectively. Interestingly VitC treatment promoted  
numerous extended processes on the cells which were in coherence with increased miniature post 
synaptic currents (mEPSCs) indicating that VitC has a positive effect on synaptic maturation of 
neurons [Lee et al., 2003]. Immunohistochemistry with anti-SVCT2 on hippocampal neurons from 
embryonic mice were shown to have intense SVCT2 in axons and faint signal in the soma[Qiu et 
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al., 2007]. Since, SVCT2 is necessary for the cells to maintain intracellular VitC, additionally 
experiments on cultured hippocampal neurons that were derived from SVCT2 knock out embryonic 
mice and embryonic wild type mice, were compared for mEPSCs, immunostaining of MAP2 which 
is a marker of dendrites and GluR1 which is an important glutamate receptor and a morphological 
correlate of mEPSCs. It was observed that hippocampal SVCT2 wild type neurons had increased 
amplitudes with smaller intervals, complex dendrites which were more in number and longer in 
length and consisted of significantly more GluR1clusters suggesting that VitC is vital for complex 
neuronal morphology and glutamatergic function of the neurons.  
 
In addition to the formation of dendritic extensions, maturation of neurons involves a vital 
mechanism of myelination which influences the speed with which the neuronal impulses are 
transmitted [Stokes, 2004]. Stevens et al demonstrated that neuronal impulse activity that has low-
frequency will have significantly reduced myelination in the neurons derived from dorsal root 
ganglia of the embryonic mice [Stevens et al., 1998] suggesting that the effect of VitC on neuronal 
maturation also includes myelination of neurons. Since the few existing data regarding effect of 
VitC on myelination are from experiments on Schwann cells, the main findings from these are 
discussed here. Addition of VitC in the medium has been shown to be a requirement for 
differentiation of Schwann cells, and VitC promoted the cells to aggregate together on the surface 
of axons and most importantly deposition of laminin, collagen type IV and heparin sulphate 
proteoglycan (HSPG) were observed only when VitC was included [Eldridge et al., 1987]. Carey 
and Todd et al have suggested that ensheathment and myelination  of axons is dependent on 
extracellular matrix formation and demonstrated it in VitC treated Schwann cells and neurons 
derived from embryonic rat dorsal root ganglia (DRGN) [Carey and Todd, 1987]. Similarly, DRGN 
derived from adult rats that were co-cultured with Schwann cells in the absence of VitC showed no 
myelin segments [Plant et al., 2002].This study also showed a marked difference in the morphology 
of the ensheathment of myelin in the VitC treated cells that revealed axons encircled by schwann 
cell cytoplasm [Plant et al., 2002]. In accordance with these findings, dietary intervention with VitC 
was shown to partially correct the pathology of neuropathy in mice by remyelination of the axon 
fibers [Passage et al., 2004]. Histological assessment of peripheral nerves of the mice that were 
treated with VitC showed a 50% higher myelination and their sheath thickness was significantly 
greater than the nerves from mice treated with placebo [Passage et al., 2004]. Data from all these 
studies support an enhancing effect of VitC on neuronal maturation. 
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3.1.5 Effect of VitC on glutamate re-uptake  
 
VitC from neurons and astrocytes has been shown by in-vitro studies to efflux into the extracellular 
space. This release of VitC into the ECF aids in the clearance of glutamate from around the synaptic 
clefts and protects the neurons from excess glutamate which would otherwise be detrimental [Rice, 
2000]. When neuroblastoma cells were incubated with increasing concentrations of glutamate, the 
transport of radiolabelled [14C] VitC into the cells was shown to be inhibited and a higher efflux of 
the radiolabelled VitC in the medium was reported as a measure of both disappearance of VitC from 
the cells and by its appearance in the culture media [May et al., 2006]. Intrastriatal infusion with 
glutamate in rats were shown to result in increased release of VitC levels for short time [Pierce and 
Rebec, 1993]. Activation of  N-methyl-D-aspartate receptor (NMDAR) by glutamate release is 
essential for excitatory synaptic transmission and synaptic plasticity but excessive stimulation of 
these receptors results in neurotoxicity [Paoletti and Neyton, 2007]. Re-uptake of glutamate 
mediated increase in extracellular ascorbate was shown to be independent of NMDAR for 
activation as NMDA antagonists did not have an effect on glutamate induced VitC release in 
striatum [Pierce and Rebec, 1993]. However, the role of glutamate re-uptake sites  in the release of 
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VitC was supported by a study that showed rapid VitC efflux following glutamate injections in 
different brain regions and the efflux of VitC was completely obstructed when both glutamate and 
glutamate uptake inhibitors of neurons and glia were co-injected [Cammack et al., 1991].  
Additionally in this study, co-injecting glial specific glutamate uptake inhibitor alone and glutamate 
demonstrated an incomplete obstruction of VitC release suggesting that neurons like glia have an 
important role in the reuptake of glutamate. Similarly it was demonstrated  that VitC release from 
striatum is blocked when the rat brain was perfused with voltage gated calcium channel blocker or 
glutamate uptake blocker, supporting that the release of VitC is dependent on glutamate uptake and 
calcium  ions [Miele et al., 1994]. In neuronal cultures derived from rat cortex, the cultures treated 
with VitC markedly reduced cell death following treatment with high levels of NMDA or glutamate 
[Majewska and Bell, 1990]. Majewska et al proposed  a mechanism of VitC in preventing excessive 
activation of NMDA receptors by altering the density of glutamate recognition sites on these 
receptors in isolated neurons [Majewska et al., 1990]. Efflux of VitC has been suggested as a 
mechanism to protect from excitotoxic effect of glutamate during stressful conditions like trauma 
where efflux of high glutamate levels have been associated to the increase in free radicals [Hillered 
et al., 1990; May et al., 2006]. During ischemia-reperfusion in rats it was demonstrated that 
extracellular VitC increases briefly during ischemia and linearly increases after reperfusion while 
glutamate levels increased linearly from the beginning of ischemia after which they decreased 
rapidly [Yusa, 2001], suggesting a VitC-glutamate heteroexchange mechanism in which glutamate 
uptake into cells parallels extracellular release of VitC. Although the mechanism of VitC efflux is 
not known these studies help to understand the importance of intracellular VitC stores in regulation 
of extracellular glutamate. Figure 6 graphically represents VitC deficiency in leading to glutamate 
toxicity around neurons. 
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3.1.6 Effect of VitC on catecholamines 
 
VitC has been shown to efficiently participate in the metabolism of catecholamines in several in 
vitro studies. In human neuroblastoma cells VitC was shown to increase the levels of precursor of 
dopamine, dihydroxyphenylalanine (DOPA), dopamine and noradrenaline [Seitz et al., 1998]. 
Additionally, gene expression analysis of the neuroblastoma cells that were treated with VitC 
showed a significant increase in tyrosine hydroxylase suggesting that VitC increases catecholamine 
levels by up-regulation of tyrosine hydroxylase [Seitz et al., 1998]. The finding of Seitz et al was in 
coherence with another in-vitro study in human neuroblast cells that reported a translational 
increase in tyrosine hydroxylase with increase in intracellular VitC [May et al., 2012a]. The 
detected norepinephrine was very low in these cells when VitC was not added and a single addition 
of VitC resulted in time-dependent increase in norepinephrine levels suggesting dependence of 
norepinephrine levels on intracellular VitC. The authors ruled out pro-oxidant nature of VitC in this 
study as the observed increase in norepinephrine level did not differ in the cell cultures that were 
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additionally treated with antioxidants, SOD or CAT [May et al., 2012a]. VitC was also shown to 
enhance norepinephrine synthesis directly when dopamine was added to neuroblast cells [May et 
al., 2012b]. Among the in-vivo studies, Meredith et al investigated the effects of VitC on 
neurotransmitters in SVCT2 knock out embryonic mice and a transgenic mice model with increased 
SVCT2[Meredith and May, 2013]. Their findings suggested that intracellular VitC levels determine 
some of the neurotransmitters in vivo, by showing lower levels of  dopamine and norepinephrine 
together with tyrosine hydroxylase protein in SVCT2-/- embryonic cortex compared to SVCT2+/+ 
and SVCT2 +/- genotypes. Lack of significant differences for serotonergic system in SVCT2 -/- was 
presumed as due to maintenance of tryptophan hydroxylase by adequate tetrahydrobiopterin 
reduction by other antioxidants like glutathione, even during VitC deficiency in the developing 
brain. Transgenic embryonic cortices with extra copies of SVCT2 showed significantly high 
dopamine, norepinephrine and serotonin compared to wild type however, they did not differ in 
tyrosine hydroxylase protein. In contrast, whole brains from SVCT2-/- embryonic mice from another 
study did not show significant differences in dopamine and norepinephrine and the authors 
suggested that dopamine β-hydroxylase can function even during severe VitC deficiency in the 
developing brain and that it may not be the cause of lethality observed in SVCT2-/- pups [Bornstein 
et al., 2003]. Similarly, a recent in-vivo study performed on Gulo-/- mice showed that VitC 
deficiency in the cortex results in non-significant decrease of dopamine levels but   dopamine 
metabolites, dihydroxyphenylacetic acid (DOPAC), 3methoxytyramine (3MT) and homovanillic 
acid (HVA), decrease significantly suggesting that VitC deficiency may alter dopamine catabolism 
[Ward et al., 2013]. A significant decrease in norepinephrine but not in dopamine levels has been 
reported in VitC deficient guinea pigs [Kaufmann et al., 1986].  Based on these findings as 
presented in figure 7, VitC deficiency may have variable effect on catecholamines depending on the 
age and type of animal model as well as the severity of VitC deficiency. 
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Chapter 4 Graphical representation of studies 
 
This section presents graphical representation of the studies that have formed the three manuscripts 
appended in this thesis. This is to provide a simplified picture of the number of animals in the study, 
dietary groups, different samples and the markers analysed. Our hypothesis in manuscript I was that 
during VitC deficiency high brain VitC relative to other organs is maintained in guinea pigs through 
induction of SVCT2. To test this hypothesis, we investigated regulation of SVCT2 expression 
following VitC deficiency as well as depletion, together with analysis of VitC transport from 
plasma to the CSF. Based on our earlier findings in which prenatal VitC deficiency was shown to 
result in an impaired brain development [Tveden-Nyborg et al., 2009; Tveden-Nyborg et al., 2012], 
we investigated the effect of prenatal VitC deficiency in both manuscript II and manuscript III. 
However, in manuscript II, the long term effect of prenatal VitC deficiency on oxidative stress was 
assessed by investigating in the postnatal guinea pig brain during deficiency and repletion. While in 
manuscript III, the short term effect of prenatal VitC deficiency on oxidative stress was assessed by 
investigating in the foetal brains during late gestational time period. Our hypothesis that led to 
manuscript II was that despite preferential retention of brain VitC, non-scorbutic VitC deficiency 
increases oxidative stress in guinea pigs. Our hypothesis that led to manuscript III was that the 
foetus is not protected from oxidative stress during maternal VitC deficiency. 
 
 
 
 
 42 
 
The study for manuscript I comprises twenty seven female (6-7 days old at the start of the study) 
Dunkin-Hartley guinea pigs that were randomized into three weight stratified groups (n=9/group). 
Control group (CTRL) received 2000 mg VitC/Kg diet, depletion group (DEPL) received 34 mg 
VitC/Kg diet and deficient group (DEF) received 100 mg VitC/Kg diet. At the end of the study 
animals were euthanized and VitC analysis was performed on plasma and cerebrospinal fluid 
(CSF), frontal cortex and cerebellum from brain, liver and kidney. mRNA and western blotting 
analysis of Svct1 and Svct2 was performed on Hippocampus, cerebellum, liver and kidney. 
 
 
 
The study which formed manuscript II comprises thirty female Dunkin-Hartley guinea pigs that 
were a subset of a large invivo study (Tveden-Nyborg et al 2012). The animals were divided to 
three dietary groups that differed only in the content of VitC (N=10/group). VitC content in the 
control feed was 900 mg/Kg diet pre-natally and 750 mg/Kg diet postnatally (pre-/postnatally 
sufficient, CTRL, 900/750 mg vitC/kg diet), VitC content in the deficient group was  100 mg/Kg 
diet both pre-natally and postnatally (pre-/postnatally deficient, DEF, 100/100 mg vitC/kg diet) and 
VitC content in the repleted group was 100 mg/Kg diet pre-natally and 750 mg/Kg diet postnatally 
(prenatally deficient/postnatally sufficient, REPL, 100/750 mg vitC/kg diet). At the end of the study 
around postnatal day 70, the animals were euthanized and hippocampus, frontal cortex and the 
cerebellum from randomized brain hemisphere (left or right) was used for mRNA and western blot 
analysis of Svct2. Plasma and brain cortex were used for biochemistry analysis which include 
ascorbate, dehydroascorbic acid, glutathione and malondialdehyde. 
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The study that formed manuscript III comprised twenty pregnant guinea pigs between gestation day 
(GD) 6-10 and the dams were randomized according to GD and body weight into two dietary 
groups (N=10/group). Dietary groups were Control: CTRL (900 mg/kg diet) and Deficient: DEF 
(100 mg/kg diet). At euthanasia three dams, one from CTRL group and two from DEF group were 
found not to have conceived and were excluded from the study. Pups were taken out by caesarean at 
GD 45 (from 5 dams of CTRL GD 45 ; 4 dams of DEF GD 45) or GD 56 ( from 4 dams of CTRL 
56 ; 4 dams of  DEF 56). Brains were removed out of the cranium and the left hemisphere from half 
of the total number of brains was used for analysis of ascorbate, malondialdehyde, alpha and 
gamma tocopherols and superoxide dismutase activity. The left hemisphere from the other half of 
the brains were used for analysis of mRNA and protein expression of caspase-3 and for western 
blotting to detect proteins modified by nitrotyrosine or hydroxynonenal. 
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5   Discussion 
 
 
5.1.1 Brain VitC is retained by unknown mechanism 
 
Our results suggest that the overall regulation of SVCT2 may not be the mechanism by which VitC 
is retained in the brain. The hypothesis 1 is hence rejected. Our results are in agreement with other 
in vivo studies [Amano et al., 2010; Meredith et al., 2011] who have shown the same by mRNA and 
protein analysis in the mice brain. VitC enters the brain CSF primarily through the choroid plexus 
[Rice, 2000]. Based on our data on CSF VitC levels, (Manuscript I) 3.5 fold higher VitC than 
plasma was always seen irrespective of differences in the VitC diet. This finding suggests that there 
may not be differences in the transport rate of VitC in the brain even during deficiency. However, it 
remains unknown if regulatory mechanism of SVCT2 may be a possibility in choroid plexus itself 
or if active function of the transporter is increased, for instance by membrane insertion as shown for 
SVCT1 [Liang et al., 2002], in this region.   
 
5.1.2 Retention of VitC or other compensatory mechanism in the brain does 
not protect from oxidative stress induced by vitamin C deficiency 
 
VitC is suggested to be essential for survival as knock out of the gene encoding Svct2 results in 
death soon after birth [Sotiriou et al., 2002]. Our results of 30% VitC retention of controls in the 
depleted guinea pigs (Manuscript I) indicate that VitC in the brain is indeed retained and underlines 
an essential role of vitC within the brain compared to other organs. Despite preferential VitC in the 
brain during deficiency there was oxidative stress by increased MDA levels (Manuscript II), 
supporting our hypothesis of VitC deficiency-imposed redox imbalance despite a relatively high 
VitC concentration in the brain. We have shown high retention of VitC and elevated MDA levels 
even in the foetal brain (Manuscript III) supporting our hypothesis 3, that foetal brain is not 
protected from oxidative stress during maternal VitC deficiency. It was interesting to find elevated 
levels of SOD activity in the foetal brains since it was suggested by others that SOD does not 
increase significantly in the guinea pig foetal brain [Mishra and Delivoria-Papadopoulos, 1988a]. 
Together with increased SOD we have also observed that deficient foetal brain does not show the 
developmental trend of decline in VitC level at near-term as compensation, in contrast to the 
controls. Compensation mechanism was also reported earlier by us in  VitC deficient weanling 
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guinea pig brain by an increased DNA repair activity [Lykkesfeldt et al., 2007] which however did 
not prevent from increased MDA levels. Reports from others have also shown compensation in the 
form of elevated endogenous antioxidant glutathione in VitC deficient Gulo-/- mice brain which did 
not prevent increase in F2 isoprostanes [Harrison et al., 2010c]. These findings suggest that 
oxidative stress is caused by VitC deficiency in spite of endogenous protective mechanisms in the 
brain. 
 
5.1.3 Effect of VitC deficiency induced oxidative stress is not known 
 
Analysis of additional protein oxidation markers in our study did not support the finding by others 
that elevated lipid peroxidation by-products like MDA may result  in oxidative modification of the 
proteins[Kim et al., 2000; Lung et al., 1993].VitC in vitro has been indicated in inhibiting apoptosis 
[Guaiquil et al., 2001; Rössig et al., 2001] but we did not see significant changes in Caspase-3 
mRNA or protein expression. Our results suggest that non-scorbutic VitC deficiency may not affect 
caspase-3 mediated apoptosis.  However, it is important to consider that activation of caspase-3 
independent mechanisms or necrosis may also likely accompany oxidative stress [Carmody and 
Cotter, 2000; Tan et al., 1998]. Based on these findings the effect of oxidative stress in VitC 
deficient brain is unclear and we could not associate hippocampal impairment from our previous 
findings to a mechanism of apoptosis. It may also be that homogenates from the whole brain instead 
of hippocampus could have masked the differences between  control and deficient groups or the 
role of apoptosis is independent of hippocampal volume reduction as shown by others [Foghi and 
Ahmadpour, 2013].  
 
5.1.4 Natural loss of Gulo makes guinea pig a valuable animal model of VitC 
deficiency 
 
One of the early signs in the onset of scurvy observed in guinea pigs is the decrease in body weight 
[Kipp et al., 1996] which was not observed in any of the animals that were subjected to chronic 
non-scorbutic VitC deficiency in our studies. The animals may be prone to scurvy approximately in 
2-3 weeks after following a dietary regime with VitC content of 40 mg/Kg diet or lesser 
[Lykkesfeldt et al., 2007] suggesting that dietary VitC manipulation in this animal model is feasible. 
VitC deficiency in guinea pigs may bear a resemblance to deficiency in humans due to the 
evolutionary loss of the Gulo gene and dietary VitC dependence [Yu and Schellhorn, 2013]. In case 
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of Gulo-/- animal model it was suggested that the animals may have developed an adaptive 
mechanism by an unknown pathway [Maeda et al., 2000]. In another study, Gulo-/- pups born to 
Gulo-/- dams were reported to have increased lipid peroxidation in brain even after including 
sufficient VitC in their diets and despite of achieving high VitC levels similar to wild type 
[Harrison et al., 2008] suggesting a genotype defect in this animal model. In a later study,  Gulo-/- 
mice following VitC depletion were shown to have retained only 10% of  brain VitC levels 
compared to Gulo-/- mice fed on control diet [Harrison et al., 2010b]. Similarly other animal models 
with exon deletions of Gulo, like the osteogenic disorder shinogi (ODS) rats and the Senescence 
marker protein 30 (SMP30) mice, were reported to have a small flux of VitC by a minute functional 
activity of Gulo and a different pathway of VitC synthesis respectively [Kondo et al., 2006; Yu and 
Schellhorn, 2013]. These findings highlight differences that could exist in animal models that do 
not have a natural loss of Gulo making guinea pigs more suitable for investigating effects of VitC 
deficiency.  
 
5.1.5 Implications of low VitC levels in human brain  
 
Our current finding of increased oxidative stress as a result of non-scorbutic VitC deficiency has 
implications for redox-imbalance in the developing brains of infants and children. In general, new-
borns are at a higher risk of oxidative stress due to reduced antioxidant defence and higher risk of 
infections due to a developing immune system [Saugstad, 2005]. VitC in plasma has been shown to 
be higher in pre-term and near-term babies while other antioxidants like vitamin E and uric acid 
were shown to increase after term into adulthood [Lindeman et al., 1989]. This is in accordance 
with the finding from human foetuses and stillborn babies ranging from 12 to 38 gestational weeks 
in which VitC levels were reported to be increasing until late gestation [Zalani et al., 1989]. These 
findings suggest that VitC likely plays a vital role during development and low VitC levels may 
compromise normal brain development, in part due to oxidative stress.  
 
5.1.6 Conclusions  
 
Brain preferentially sequesters VitC at all times but not by the mechanism of an overall regulation 
of Svct2 expression. Non-scorbutic VitC deficiency causes oxidative stress in the brain and 
compensatory mechanisms does not protect the foetal brain from oxidative stress as a result of 
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maternal low intake of VitC. The molecular effects of VitC in the brain are obscure and need 
attention to discover the markers beyond scurvy to extend the line of thought from our earlier and 
current studies that non-scorbutic VitC deficiency disrupts normal brain development. 
 
5.1.7 Future perspectives based on current findings 
 
Based on our current findings on Svct2, if the preferential retention of brain VitC is not by the 
mechanism of Svct2 expression, then it could be due to functional regulation. Increased Svct2 
activity may likely explain the sequestration of brain VitC. Alternatively ratio of the membrane 
localized/cytosolic expression of the transporter may be revealed by immunohistochemistry. 
Western blotting assessment may also give an indication of membrane localized transporters by 
analysis of membrane protein fractions of the brain lysates.  
 
The effects of non-scorbutic VitC deficiency in the brain are still unclear and can only be 
recognized by showing more evidence from in vivo studies. It is important to identify the 
physiological consequences of oxidative stress caused by VitC deficiency because increase in 
oxidizing agents may affect other cellular activities [Sies, 1997]. One approach to investigate such 
consequences would be to investigate markers that indicate sources of biological oxidizing agents 
like NADPH oxidase, xanthine oxidase etc. Another approach is to investigate the cell viability by 
investigating molecular markers of apoptosis, necrosis and inflammation in the brain. Based on our 
previous finding on delayed cellular migration in the VitC deficient hippocampus [Tveden-Nyborg 
et al., 2012],   immunohistochemistry with focus on markers of microtubule associated proteins may 
add support to our hypothesis of non-scorbutic VitC deficiency causing disrupted brain 
development.  
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HIGHLIGHTS 
• Effects of vitamin C deficiency on the regulation of specific transporters in vivo 
• The Svct1 transporter in liver is increased in deficient and decreased in depleted  
• No effect on Svct1  and Svct2 expression in kidney and brain sections 
• Transport rate from plasma to CSF appears un-affected by dietary regime 
 
 
 
 
  
ABSTRACT  
The effects of vitamin C deficiency and depletion on the expression of transporters SVCT1 and 
SVCT2 in selected tissues and the transport from plasma to cerebrospinal fluid (CSF) was 
investigated in a guinea pig model. In deficient SVCT1 was increased in the liver whereas a reduced 
SVCT1 expression and increased Svct2 mRNA suggests a potential shift in transporter expression in 
the liver of depleted animals. The plasma:CSF ratio demonstrated a constant transport irrespective 
of dietary regime. The study adds novel information to the complex regulation maintaining vitamin 
C homeostasis in vivo during states of deficiency. 
  
INTRODUCTION 
An association between vitamin C (vitC) deficiency and the propagation of diseases such as 
cardiovascular disease and metabolic syndrome has been suggested by both epidemiological 
studies in humans and in experimental animal models (1). VitC deficiency (defined in humans as a 
plasma concentration below 23 µmol/l (2)) affects about 10% of the adult population in the 
industrialized world, with markedly increased prevalence in specific subgroups such as smokers 
and low-income citizens (3;4). As vitC is differentially distributed within the organism, there is 
reason to believe that a state of deficiency may impose local alterations to specific transporters. 
However, it is presently not known to what extent the regulation of the overall vitC homeostasis in 
the body is affected by various degrees of deficiency (5). 
VitC displays complex dose-dependent pharmacokinetics and is subject of tight homeostatic 
regulation maintaining a differential tissue specific distribution (5;6). In short, absorbed vitC is 
found almost exclusively on its anionic reduced form, ascorbate (Asc) at physiological pH while its 
two-electron oxidation product, dehydroascorbic acid (DHA), is only present in negligible amounts 
(7). Though both passive and facilitated diffusion occur, vitC transport is primarily achieved by 
sodium-coupled vitamin C co-transporters SVCT1 and 2 (SLC23A1 and SLC23A2 respectively) 
governing gastrointestinal absorption, distribution to target tissue and renal reabsorption of Asc 
(5). The brain upholds a uniquely high Asc concentration and maintains high levels even during 
prolonged states of deficiency (8;9), thought to be primarily due to SVCT2-mediated transport. A 
pivotal role of vitC in the brain is supported by several in vivo findings; deficiency leading to 
impaired development and reduced function (10-14).  
Although the tight control of vitC homeostasis and its tissue specific distribution has been 
recognized for years, little is known about if and how vitC deficiency affects the specific regulatory 
mechanisms. In vitro data has shown alterations of SVCT1 and 2 expression in response to changes 
in Asc concentration in culture medias (15;16). However, neither short- nor long-term in vivo 
studies of vitC transport to the brain have been able to demonstrate a relationship between vitC 
deficiency and increased SCVT2 expression, leading to speculations of possible alternative 
mechanisms for vitC transport (17). 
Using the guinea pig as a model of diet-induced vitC deficiency, this study investigates if mRNA 
and protein expression of SVCT1 and 2 transporters in various tissues are affected by mild or 
severe chronic vitC deficiency. The study provides insight to the mechanisms underlying the 
regulation of overall vitC homeostasis and putative tissue-specific characteristics with emphasis on 
the blood-brain transport assessing vitC concentrations in plasma, cerebrospinal fluid and brain 
sections. 
 
MATERIALS AND METHODS 
In vivo study 
The study was approved by the Danish Animal Experimentation Inspectorate under the Ministry of 
Justice. Twenty seven female 6-7-days old Dunkin-Hartley guinea pigs (Charles Rivers Lab, Kisslegg, 
Germany) were included. Upon arrival animals were equipped with a subcutaneous microchip for 
identification (PET-CHIP ID, e.vet®, Danworth Farm, West Sussex, UK) and randomized into three 
weight-stratified dietary groups (n=9/group) receiving a purified, standard guinea pig diet differing 
only in vitC levels (Research Diets, New Brunswick, NJ, USA). The dietary groups consisted of a 
depletion group (DEPL) receiving vitC below the detectable limit of 34 mg/kg diet; a marginally 
deficient group (DEF:100 mg vitC/kg diet) and a control group (CTRL:2000 mg vitC/kg diet). 
Animals were group housed in floor pens in an enriched environment and allowed fresh water, 
feed and hay ad libitum. By analysis, the hay did not contain vitC. Animals were tended several 
times daily by trained staff and body weights closely monitored.  
Euthanasia 
Animals were anesthetized in randomized order by inhalation of Isoflurane (Isoba Vet 100%, 
Intervet International, Boxmeer, The Netherlands). At the disappearance of voluntary reflexes 
thoracotomy was performed and an intracardial blood sample of 2-3 mL was obtained  (18G 
hypodermic needle and 5 mL syringe flushed with 15% tripotassium-EDTA solution) (18), and the 
animal subsequently euthanized by exsanguination. Plasma samples were stabilized and 
immediately frozen on dry ice. Cerebrospinal fluid (CSF) was drained by glass-pipette through the 
foramen major applying a light vacuum. Samples were immediately frozen on dry ice. Tissue 
samples were harvested; and snap-frozen in liquid nitrogen for mRNA and protein analysis or 
frozen on dry ice for biochemical analysis. All tissues, CSF and plasma were placed in -80 °C for 
storage prior to analysis.  
Ascorbate analysis 
Blood samples for vitC analysis were centrifuged at 2000 x g for 5 min at 4 °C. Plasma and CSF 
samples were immediately mixed with an equal volume of 10% meta-phosphoric acid (MPA) 
containing 2 mM EDTA (Merck, Whitehouse Station, NJ, USA), centrifuged, and the supernatants 
were stored at -80°C until analysis (18). Tissue samples (app. 0.5 g) were homogenized in PBS, 
centrifuged at 16000 x g for 1 min at 4 °C and stabilized with MPA as above. Analysis in MPA 
stabilized plasma, CSF and tissue homogenate were performed by high-performance liquid 
chromatography (HPLC) with coulometric detection as described previously (19).  
Gene expression analysis 
Approximately 20 mg tissue of kidney, liver, cerebellum and hippocampus were used for isolation 
of RNA as previously described (20). Concentration and purity of the extracted RNA was measured 
by spectrophotometric analysis (NanoDrop® 1000 Spectrophotometer; Thermo Scientific, 
Wilmington, DE, USA). cDNA synthesis was achieved by reverse transcription of 2 µg of RNA as 
previously described (20). 
All cDNA samples were tested for DNA contamination by conventional polymerase chain reaction 
(PCR) before submitting to real-time quantitative PCR (Q-PCR) using an intron-spanning β-actin 
primer set (F5’:GTAAGGACCTCTATGCCAACAC and R5’:ATGCCAATCTCATCTCGTTTTCT). Only 
samples which did not display DNA contamination were admitted in the study. To confirm 
specificity of target genes PCR products were sequenced (LGC Genomics, Berlin, Germany). Real-
time quantitative (Q)-PCR analysis was performed in triplicates in white 96 well plates on a 
LightCycler® LC480 with LightCycler® 480 SYBR Green 1 Master (all from Roche, Basel, 
Switzerland). Standard curves were created for individual primer-sets on calibrator dilutions, and 
the coherent efficiencies applied in the later expression analysis. For Q-PCR analysis, negative 
controls (nuclease-free water) and calibrator samples were included in all runs. Expression ratios 
of the two target genes Svct1 and Svct2 were acquired by normalization to the reference gene 
Gapdh (primer sequences are shown in table 1). 
Protein extraction 
Approximately 20 mg tissue (kidney, liver and cerebellum and hippocampus) was homogenized in 
250 µL cold radio-immunoprecipitation assay (RIPA) buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1% 
Triton X-100, 0.5% sodium deoxycholate, and 0.1% Sodium Dodecyl Sulfate [SDS]) containing 
Protease Inhibitor Cocktail diluted 1:100 (Sigma-Aldrich, St. Louis, MO, USA) and centrifuged for 10 
min at 1200 rpm at 4 °C. The supernatant was transferred to fresh Eppendorf tubes and frozen 
immediately at -80 °C. Aliquots were used for determining protein concentration using the 
Bradford Assay (21) and performed in triplicates (samples containing 100 mg Coomassie Brilliant 
Blue G-250, 50 mL 96% ethanol, 100 mL 85% phosphoric acid and 500 mL milli-Q water) at 595 nm 
by spectrophotometry (SpectraMax Plus 384 plate reader; Molecular Devices, Sunnyvale, CA, 
USA). Concentrations were calculated based on standard dilutions of Bovine Serum Albumin 
(Sigma-Aldrich) in Phosphate Buffered Saline (Dulbecco’s PBS). 
Western Blot analysis 
Samples containing 40 µg (liver, hippocampus and cerebellum) or 50 µg (kidney) protein were 
adjusted with nuclease-free water to achieve  a volume of 32.5 µL, prior to adding  NuPage® LDS 
Sample Buffer and NuPage® Sample Reducing Agent (LifeTechnologies/Invitrogen, Carlsbad, CA, 
USA). Following preheating (10min/70°C) samples were transferred to NuPage® Novex 4-12% Bis-
Tris Midi Gels and run in duplicates at 200 Volts in NuPage® MOPS SDS Running Buffer containing 
NuPage® Antioxidant (Life technologies). A calibrator, a positive and a negative control was 
included on all gels. The separated proteins were blotted onto PVDF Transfer Membranes (TE 77 
PWR semi-wet transfer unit ;GE Healthcare, NJ, USA) with NuPage® Transfer Buffer and NuPage® 
Antioxidant (Life technologies) at 169 mA for 45 min, followed by 2% blocking solution ( 1 hr in 
PBS, 0.1% Tween® 20 and ECL PrimeTM blocking agent (GE Healthcare) followed by incubation with 
primary antibody (0.4 µg/mL goat anti-SVCT1 (LOT H1111) or 1 µg/mL goat anti-SVCT2 (LOT 
A2313) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and 0.12 µg/mL mouse anti-actin (LOT 
NG1848416) (Millipore, Billerica, MA, USA,) in blocking solution at 4 °C overnight. Membranes 
were washed in PBS with 0.1% Tween® 20 and incubated with secondary antibody (0.1 µg/mL 
rabbit anti-goat for anti-SVCT1 and anti-SVCT2 and 0.04 µg/mL goat anti-mouse for anti-actin 
(Santa Cruz Biotechnology) in 2% blocking solution for 1 hour. Bands were visualized with 
AmershamTM ECLTM Prime Western Blotting Detection Reagent (GE Healthcare) using the 
BioSpectrum® Imaging System (UVP, Upland, CA, USA). Product size was established relative to 
MagicMarkTM XP Western Protein Standard (Invitrogen). To determine band intensity, 
densiometry was performed using VisionWorks® Analysis Software (UVP) and target values 
normalized to the corresponding actin band and calibrator. Specificity of the primary SVCT1 and 
SVCT2 antibodies was confirmed by a pre-absorption test with blocking peptide in a 5:1 ratio of 
concentrations (Santa Cruz Biotechnology). 
Statistical analyses 
Data was analyzed using Statistica software (Statistica, version 9; StatSoft, Tulsa, OK, USA) applying 
a two-way ANOVA followed by Tukey’s multiple comparisons posthoc test in case of significance. 
Homogeneity of variance was tested by Levene’s test; in case of non-homogeny, data was log-
transformed prior to analysis. A p-value below 0.05 was considered statistically significant. 
 
RESULTS 
Bodyweights 
Bodyweights were initially monitored bi-weekly and daily from day 14 due to potential risk of 
scurvy in the depleted group (figure 1). As expected, bodyweights of CTRL and DEF animals did not 
differ at euthanasia, however was significantly decreased in DEPL animals (P<0.05) (Table 1). 
When normalized to average bodyweight, brain weight was not found to be significantly different 
between groups.  
 
Tissue levels of ascorbate 
As expected, CTRL animals displayed a significantly higher Asc level in plasma, CSF and in all 
measured tissues compared to DEF and DEPL (P<0.001 in plasma; P<0.0001 liver, kidney, CSF and 
P<0.05 in brain); DEF animals were significantly lower than CTRLs and higher than DEPL on all 
accounts (Table 1). In CTRL animals liver and brain total Asc did not differ, however in DEF animals 
the brain maintained an increased Asc concentration compared to the liver and kidney, a 
phenomenon even more pronounced in DEPL animals. The CSF reflected the reduced availability 
of Asc, but interestingly, a concentration of approximately 3.5 times that of plasma in all three 
dietary regimes was maintained (no significant different in CSF:plasma ratio between groups).  
Within brain sections, the frontal cortex consistently showed higher Asc concentrations than the 
cerebellum in CTRL, DEF and DEPL (P<0.001; P<0.01 and P<0.05 respectively), displaying both an 
effect of diet (P<0.001) and an effect of tissue (P<0.001).  
 
SVCT1 and SVCT2 expression analysis 
In the liver, an increase in mRNA expression of Svct1 relative to the housekeeping gene Gapdh was 
recorded in DEF animals (P<0.05) while a decrease in DEPL animals (P<0.05) compared to CTRL was 
observed. This pattern in SVCT1 expression was confirmed by Western blot analysis on protein 
levels (P<0.05). Svct2 mRNA expression was increased in DEPL (P<0.05); CTRL and DEF not 
differing, however a tendency to an increased expression in DEF was noted (figure 2). No 
detectable difference was recorded in SVCT2 protein expression between groups. No differences 
were detected in either protein or mRNA expression of SVTC1 or SVCT2 in any of the other 
investigated samples.  
 
 
DISCUSSION 
The present study shows an increased expression of the Svct1 transporter in the liver during 
deficiency but a decrease in expression in DEPL animals on both mRNA and protein level. In 
contrast, expression of the Svct2 transporter was increased in DEPL (mRNA) but not DEF. Though 
not supported by the Western blot analysis, a tendency towards an increased Svct2 expression is 
noted. An increase in SVCT1 expression has been shown in vitro in human hepatic cell lines 
subjected to Asc depletion with increased SVCT1 expression but no significant change in SVCT2, 
suggesting a transcriptional regulation in response to Asc depletion of culture media (22). 
Likewise, primary hepatocyte culture from long term vitC depleted (33 days) in smp30/gnl-/- 
knock-out mice displayed increased Asc transport and an increase in both Svct1 and an even more 
pronounced increase in Svct2 (70% compared to Asc sufficient) mRNA expression (23). In 
agreement with our data, no effect of in vivo depletion on Asc transporters was detected in either 
kidney or brain (23). The expression pattern found in the present study indicates a differential 
effect of dietary regimes on the liver and suggests a Svct1 up-regulation due to chronic but 
moderate deficiency, whereas a severe state of deficiency appears to shift expression from SVCT1 
towards an increase in SVCT2. This is consistent with the transporter characteristics of the SVCTs. 
SVCT1 is considered a high-capacity but low affinity transported (Km≈65-252) while SVCT2 is a low-
capacity high affinity (Km≈8-69) (5;22). Thus, in order to salvage the diminutive amounts of Asc 
available in plasma and limit its depletion, the liver apparently attempts to further adapt by 
increasing absorption through a change in its transporter profile. This is of course, provided that 
the recorded increase in Svct2 mRNA expression translates to functional protein. 
 
As expected, Asc concentrations in the brain reflected the imposed decreases in Asc supply but 
remained much higher than in liver and kidney for both DEF and DEPL groups. Agreeing with 
reports from various species including guinea pigs, Asc concentrations differed significantly 
between brain-sections, the frontal cortex consistently displaying higher levels than the 
cerebellum most likely reflecting differences in neuronal density (24-26). In the present study, no 
change in SVCT2 (on either mRNA or protein level) due to the imposed vitC deficiencies could be 
demonstrated in the investigated brain areas. This is consistent with previous findings in 
chronically deficient (100mg vitC/kg feed) guinea pigs compared to controls (325mg vitC/kg feed), 
in which no effect on Svct1 or 2 mRNA levels was seen in liver or brain (20). In smp30/gnl -/-  
knock-out mice, mRNA expression of Svct1 and 2 in the liver was increased following vitC 
depletion, whereas no effect on brain was reported (23). Likewise, an increase in Svct2 mRNA in 
the liver has been reported following vitC depletion in developing gulo -/- mice, and though data 
points towards increased Svct2 expression in the brain, the effect was non-significant (17). 
 
The conundrum of the brain’s ability to maintain a uniquely high Asc concentration even during 
severe and long-term states of deficiency without increasing levels of the specific transporter has 
led to speculations of a yet undiscovered mechanism of transport and regulation of vitC to the 
brain (17). No significant change in plasma/CSF transport rate could be detected in the current 
study; the concentration in CSF remaining around 3.5 fold higher than that of plasma despite 
dietary regimes. Whether this transport is due to an increase in transporters located in the coroid 
plexus (Asc transport) and/or blood-brain-barrier or whether transporters are permanently 
excessively expressed to safeguard Asc supply to the brain remains to be disclosed. 
 
 
CONCLUSION 
We conclude that a dietary imposed chronic vitC deficiency in guinea pigs leads to changes in the 
SVCT1 and SVCT2 expression in the liver but not in brain or kidney. With respect to the hypothesis 
of the putative modulation of brain transport during deficiency, the finding of a constant vitC 
concentration ratio from plasma to CSF regardless of dietary status reveals that this interface is 
not the site of modulation. 
 
ACKNOWLEDGMENTS 
This project was partially funded by the Danish National Research Councils, The Lifepharm Centre 
for In Vivo Pharmacology and University of Copenhagen. The authors wish to thank Annie Bjergby 
Kristensen, Elisabeth Veyhe Andersen and Joan E. Frandsen for excellent technical assistance. The 
authors declare no conflicts of interest that could influence the present work. 
  
 
Reference List 
 
 1.  Tveden-Nyborg P, Lykkesfeldt J. Does vitamin C deficiency increase lifestyle-associated vascular 
disease progression? - Evidence based on experimental and clinical studies. Antioxid Redox Signal 
2013. 
 2.  Smith JL, Hodges RE. Serum Levels of Vitamin-C in Relation to Dietary and Supplemental Intake of 
Vitamin-C in Smokers and Nonsmokers. Annals of the New York Academy of Sciences 1987;498:144-
52. 
 3.  Lykkesfeldt J. Smoking depletes vitamin C: Should smokers be recommended to take supplements? 
In: Halliwell B, Poulsen HE, eds. Springer Verlag 2006:237-60. 
 4.  Frikke-Schmidt H, Tveden-Nyborg P, Lykkesfeldt J. Vitamin C in human nutrition. In: Hermann W, 
Obeid R, eds. Vitamins for prevention of human diseases. De Gruyter 2011:323-47. 
 5.  Lindblad M, Tveden-Nyborg P, Lykkesfeldt J. Regulation of vitamin C homeostasis during deficiency. 
Nutrients 2013;5:2860-79. 
 6.  Wilson JX. Regulation of vitamin C transport. Annu Rev Nutr 2005;25:105-25. 
 7.  Dhariwal KR, Hartzell WO, Levine M. Ascorbic acid and dehydroascorbic acid measurements in human 
plasma and serum. Am J Clin Nutr 1991;54:712-6. 
 8.  Frikke-Schmidt H, Tveden-Nyborg P, Birck MM, Lykkesfeldt J. High dietary fat and cholesterol 
exacerbates chronic vitamin C deficiency in guinea pigs. Br J Nutr 2011;105:54-61. 
 9.  Lykkesfeldt J, Trueba GP, Poulsen HE, Christen S. Vitamin C deficiency in weanling guinea pigs: 
differential expression of oxidative stress and DNA repair in liver and brain. Br J Nutr 2007;98:1116-9. 
 10.  Sotiriou S, Gispert S, Cheng J et al. Ascorbic-acid transporter Slc23a1 is essential for vitamin C 
transport into the brain and for perinatal survival. Nature Medicine 2002;8:514-7. 
 11.  Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. 
Free Radic Biol Med 2009;46:719-30. 
 12.  Harrison FE, Dawes SM, Meredith ME, Babaev VR, Li L, May JM. Low vitamin C and increased 
oxidative stress and cell death in mice that lack the sodium-dependent vitamin C transporter SVCT2. 
Free Radic Biol Med 2010;49:821-9. 
 13.  Tveden-Nyborg P, Johansen LK, Raida Z, Villumsen CK, Larsen JO, Lykkesfeldt J. Vitamin C deficiency in 
early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in 
guinea pigs. Am J Clin Nutr 2009;90:540-6. 
 14.  Tveden-Nyborg P, Vogt L, Schjoldager JG et al. Maternal vitamin C deficiency during pregnancy 
persistently impairs hippocampal neurogenesis in offspring of guinea pigs. PLoS One 2012;7:e48488. 
 15.  Savini I, Rossi A, Pierro C, Avigliano L, Catani MV. SVCT1 and SVCT2: key proteins for vitamin C uptake. 
Amino Acids 2008;34:347-55. 
 16.  MacDonald L, Thumser AE, Sharp P. Decreased expression of the vitamin C transporter SVCT1 by 
ascorbic acid in a human intestinal epithelial cell line. Br J Nutr 2002;87:97-100. 
 17.  Meredith ME, Harrison FE, May JM. Differential regulation of the ascorbic acid transporter SVCT2 
during development and in response to ascorbic acid depletion. Biochem Biophys Res Commun 
2011;414:737-42. 
 18.  Lykkesfeldt J. Ascorbate and dehydroascorbic acid as biomarkers of oxidative stress: validity of clinical 
data depends on vacutainer system used. Nutr Res 2012;32:66-9. 
 19.  Lykkesfeldt J. Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: 
analytical reproducibility and long-term stability of plasma samples subjected to acidic 
deproteinization. Cancer Epidemiol Biomarkers Prev 2007;16:2513-6. 
 20.  Tveden-Nyborg P, Hasselholt S, Miyashita N, Moos T, Poulsen HE, Lykkesfeldt J. Chronic Vitamin C 
Deficiency does not Accelerate Oxidative Stress in Ageing Brains of Guinea Pigs. Basic Clin Pharmacol 
Toxicol 2011. 
 21.  Bradford MM. Rapid and Sensitive Method for Quantitation of Microgram Quantities of Protein 
Utilizing Principle of Protein-Dye Binding. Analytical Biochemistry 1976;72:248-54. 
 22.  Reidling JC, Rubin SA. Promoter analysis of the human ascorbic acid transporters SVCT1 and 2: 
mechanisms of adaptive regulation in liver epithelial cells. Journal of Nutritional Biochemistry 
2011;22:344-50. 
 23.  Amano A, Aigaki T, Maruyama N, Ishigami A. Ascorbic acid depletion enhances expression of the 
sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of 
SMP30/GNL knockout mice. Arch Biochem Biophys 2010;496:38-44. 
 24.  Harrison FE, Green RJ, Dawes SM, May JM. Vitamin C distribution and retention in the mouse brain. 
Brain Res 2010;1348:181-6. 
 25.  Rice ME, Lee EJ, Choy Y. High levels of ascorbic acid, not glutathione, in the CNS of anoxia-tolerant 
reptiles contrasted with levels in anoxia-intolerant species. J Neurochem 1995;64:1790-9. 
 26.  Rice ME, Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione 
between neurons and glia. Neuroscience 1998;82:1213-23. 
 27.  Clark AG, Rohrbaugh AL, Otterness I, Kraus VB. The effects of ascorbic acid on cartilage metabolism in 
guinea pig articular cartilage explants. Matrix Biol 2002;21:175-84. 
 
 
  
  
Table 1: Primer sequences of housekeeping and target genes. 
Gene Primer sequence (5’-3’) Product size NCBI Acc. No. 
Svct1(20) F: TCCGACAGATTATGGCTTCC 211 AF410935  
R: GCACAAGCATAGTAATCACCGA 
Svct2(27) F: GTCCATCGGTGACTACTA 114 AF411585  
R: ATGCCATCAAGAACACAGGA 
Gapdh(20) F: GCACCGTCAAGGCTGAGAAT 227 DQ403052  
R: CATCACGAACATAGGGGCATC 
 
 
 
 
 
 
  
Table 2: Vitamin C levels in selected tissues  
 
Results are presented as means ±SD. Dissimilar superscripts denotes values of significant difference.  
#: Difference in ascorbate concentration in brain sections (frontal versus cerebellum) within the dietary 
group. I.e. Asc in frontal cortex is significantly higher than in cerebellum, P<0.0001(CTRL).   
*P<0.05; ***P<0.001; ***P<0.0001. 
 
 
 
 
 
 
 
 
 
 
 
 Control (CTRL) 
2000 mg/kg feed 
n=9 
Deficient (DEF) 
100 mg/kg feed 
n=9 
Depleted (DEPL) 
0 mg/kg feed 
n=9 
Plasma total ascorbate 
(µmol/L) 
73.5 ± 31.5a 5.08 ± 2.8b** 0.99 ± 0.1c** 
CSF total ascorbate  
(µmol/L) 
247.9 ± 30.8a 16.6 ± 8.5b*** 3.3 ± 1.3c*** 
Liver total ascorbate 
(nmol/g tissue) 
1762.8 ± 554.4a 269.4 ± 131b**  26.8 ± 2.9c** 
Kidney total ascorbate 
(nmol/g tissue) 
757.0 ± 170.6a 166.6 ± 78.8b** 13.8 ± 4.4c** 
Frontal cortex total 
ascorbate (nmol/g tissue) 
1654.6 ± 156.2a,#*** 826.5 ± 125.0b*,#** 518.5 ± 22.4c*,#* 
Cerebellum total ascorbate 
(nmol/g tissue) 
1013.6 ± 333.1a 584.9 ± 161.1b* 313.2 ± 64.0c* 
Body weight at euthanasia 
(g) 
312 ± 21.94a 313 ± 27.59a 275 ± 78b* 
Brain weight normalized to 
BW 
3.4 ± 0.32 3.5 ± 0.41 3.1 ± 0.30 
 
 
 
 
 
 
 
 
FIGURE LEGENDS 
 
Figure 1: Recorded bodyweights in the dietary groups during the study period. 
 
 
As weight loss is an initial sign of emerging scurvy (9) and a humane end-point of this study, 
bodyweights were monitored closely. As expected weight loss appeared in the DEPL group 
(P<0.05), after which all animals were euthanized before any clinical symptoms of scurvy could be 
detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Effect of vitC deficiency on the expression of SVCT1 and SVCT2 in the liver. 
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On both mRNA and protein level (panel A and C) SVCT1 expression was increased in DEF and 
decreased in DEPL. An increase in Svct2 mRNA expression was found in DEPL (panel B) and though 
this also appears to be present in DEF a difference to CTRL was not significant. No effect on SVCT2 
protein was found between groups (panel D). *P<0.05. 
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Abstract
Background: Vitamin C (VitC) has several roles in the brain acting both as a specific and 
non-specific antioxidant. The brain upholds a very high VitC concentration and is able to 
preferentially retain VitC even during deficiency. The accumulation of brain VitC levels 
much higher than in blood is primarily achieved by the sodium dependent VitC transporter 
(SVCT2). This study investigated the effects of chronic pre-and postnatal VitC deficiency as 
well as the effects of postnatal VitC repletion, on brain SVCT2 expression and markers of 
oxidative stress in young guinea pigs. 
Results: Biochemical analyses demonstrated significantly decreased total VitC and an 
increased percentage of dehydroascorbic acid as well as increased lipid oxidation
(malondialdehyde) in the brains of VitC deficient animals (p<0.0001) compared to controls.
VitC repleted animals were not significantly different from controls. No significant changes 
were detected in either gene or protein expression of SVCT2 between groups or brain 
regions. 
Conclusion: In conclusion, chronic pre-and postnatal VitC deficiency increased brain redox 
imbalance but did not increase SVCT2 expression. Postnatally repleted pups did not display 
the redox imbalance observed in deficient counterparts. Our findings show potential
implications for VitC deficiency induced negative effects of redox imbalance in the brain and 
provide novel insight to the regulation of VitC in the brain during deficiency.
Key Words:
• Vitamin C deficiency
• SVCT2
• Redox imbalance
• Oxidative stress
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BACKGROUND
Vitamin C (VitC) has multiple roles in the brain acting both as a non-specific antioxidant [1,
2] and as a co-factor of enzymatic reactions including collagen- and catecholamine synthesis
[3, 4] as well as being involved in neuronal glutamate re-uptake [3] . VitC is preferentially 
retained in the brain relative to other organs even during states of deficiency, emphasizing the
prominence of this essential micronutrient in the brain [5, 6]. Due to a high level of cellular 
metabolic activity and a high content of lipids, the brain, and particularly the growing brain,
is prone to oxidative stress and lipid peroxidation [7]. Oxidative stress is defined as an 
imbalance in redox-homeostasis, e.g., between free radicals and the coherent protection by 
anti-oxidants [8]. Hence, oxidative stress is propagated when VitC supply is insufficient [9,
10], hereby leading to imbalance in redox homeostasis and subsequent progressive cellular
damage. Under such circumstances, lipid peroxidation has been a principal biomarker to 
assess oxidative damage in the brain and has been suggested to be associated with cognitive 
impairment and neurodegenerative diseases [11, 12].
VitC enters the brain primarily in its reduced form, ascorbate (ASC) [13]. From the blood 
stream ASC is transported against a concentration gradient into brain through the choroid 
plexus to the cerebrospinal fluid (CSF) and from here reaches the brain to achieve 
homeostasis [3]. The majority of VitC transport to the brain is accomplished through an 
active transport by the sodium dependent vitamin C transporter (SVCT2), allowing VitC
levels to reach concentrations 10 fold higher than that of the blood [14, 15]. Mice lacking this 
transporter have been shown to die immediately after birth, displaying respiratory failure and 
haemorrhage in the brain [16, 17]. A study with Svct2+/- mice compared to wild type 
demonstrated that VitC levels in brain cortex were genotype dependant with higher VitC
content in mice homozygous for Svct2(+/+) compared to heterozygous counterparts [17].
3 
 
Within the brain  differential VitC retention in specific brain regions has been reported [18].
Dietary intervention studies have shown increases in Svct2 mRNA expression in the liver, 
both in vitro and in vivo, but not in the brain following VitC deficiency in mice unable to 
synthesize VitC (Gulo-/-) [19, 20]. However analysis of the in vivo SVCT2 expression in the 
cerebellum disclosed an increase in protein levels but not mRNA following VitC deficiency 
in adult Gulo -/+ mice. Although the increase was not significant, it showed an apparent
response to reductions in VitC supply unlike in cortex of the same group, which was 
suggestive of tissue dependent regulation of SVCT2 [20, 21].
Like humans and primates, guinea pigs cannot synthesize VitC due to mutation in the L-
gulono-γ-lactone-oxidase gene and therefore VitC must be supplied in the diet to prevent the 
development of scurvy [22]. Hence, the guinea pig is considered a valuable model to 
investigate effects of VitC deficiency. We have previously shown that VitC deficiency in 
newly weaned guinea pigs elevates DNA repair and oxidative stress [23], and is associated 
with an impairment of spatial memory and reduction of hippocampal neurons in young 
guinea pigs with low levels of VitC [24]. In a recent study, we have shown a persistent 
hippocampal volume reduction in prenatally deficient animals regardless of postnatal VitC 
repletion [25].
In this study, we investigated if a chronic pre- and postnatal VitC deficiency in guinea pigs
leads to postnatal (day 70, P70) lipid peroxidation in the brain, if prenatal damage persists 
following postnatal repletion, and if differences observed associate to gene and protein 
expression of SVCT2 transporter in three brain regions, hippocampus (HP), cerebellum (BC) 
and brain frontal cortex (BFC). We show that chronic pre- and postnatal VitC deficiency 
leads to redox imbalance by increase in ascorbate oxidation and malondialdehyde (MDA) in 
young guinea pig brains, however this does not result in changes in SVCT2 expression.
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RESULTS
Biochemical analyses
As expected, VitC deficiency was reflected in the VitC concentrations in brain and plasma 
with lower levels in DEF animals and the %DHA in plasma and brain showing elevated 
oxidation of the VitC pool (p<0.0001 for both ; Table 2). No significant differences were 
found between VitC levels in CTRL and REPL groups demonstrating that REPL pups 
reached CTRL-status for VitC (Table 2). VitC status significantly affected brain MDA 
concentrations (p<0.0001) with the DEF group displaying higher lipid oxidation compared to 
CTRL or REPL (p<0.0001; Table 2). No significant difference in MDA level was found 
between CTRL and REPL groups at day 70. In contrast to MDA levels, dietary VitC did not 
affect brain glutathione levels significantly.
Svct2 expression
The PCR analysis of Svct2 expression from HP displayed a tendency to increase in DEF 
animals, but this was not significant (Figure 1A). No significant differences were observed in
either BC or BFC regions between the three groups (Figures 1B & 1C).Western blot was 
performed to investigate if VitC deficiency affected SVCT2 protein levels from the three 
brain regions. Samples resulted in a doublet that may correspond to glycosylated and non-
glycosylated forms (bands above 60 kDa and ~70kDa) (Figure 2A), as has been previously 
reported [31, 32]. Incubation with antibody specific blocking peptide successfully prevented 
both bands (Figure 2B), confirming specificity of the SVCT2 antibody in both guinea pig and 
mouse (positive control) lysates (Figures 2A & 2B). A few brain lysates gave rise to an 
additional 80 kDa band following anti-SVCT2 blots. This was detected even after pre-
5 
 
absorption with blocking peptide, confirming it to be a non-specific band (Figure 2B).
Although we did not quantify band density between the three regions of the brain, 
hippocampus samples showed intense bands compared to the samples from the other two 
brain regions, with the faintest bands pertaining to samples from BFC. No significant changes 
were found between the three groups within the measured brain regions (Figure 3) suggesting 
that SVCT2 expression is not induced by the dietary regimes applied in this study.
DISCUSSION
In the present study, we wanted to assess the effect of chronic pre- and postnatal VitC 
deficiency on oxidative stress markers and VitC transporter expression in the brain of young 
guinea pigs (P70), and if prenatal effects persisted after postnatal repletion. As expected,
deficient animals had significantly lower levels of VitC in plasma while VitC levels did not 
differ between CTRL and REPL groups in spite of the difference in VitC status of their 
mothers (data not shown) [33]. DEF animals also showed increased oxidative stress measured 
by ascorbate oxidation (%DHA) and MDA. Other studies have reported MDA as a marker of 
lipid oxidation in the brain and increases in %DHA is associated to an enhance interaction 
between VitC and oxidants. The findings of both lipid oxidation and the promotion of VitC 
oxidation suggests increased levels of oxidative stress in DEF animals, which could result in 
disruption of the established metabolic pathways in the brain.
Low levels of VitC has been shown to increase GSH synthesis in brain of Gulo-/- mice [34]
and VitC has also been suggested to modulate GSH regulation in human erythrocytes [35]. 
Our data did not show any significant changes in brain total GSH suggesting that the 
chronically low levels of VitC in this study may still be sufficient to spare GSH in the brain.
Moreover, VitC is capable of maintaining other anti-oxidants such as vitamin E in a reduced 
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state [36]. However, previous investigations in VitC depleted guinea pigs have shown that 
despite the positive retainment of VitC in the brain during acute VitC deficiency, oxidative 
stress is not prevented and may have detrimental consequences for cellular function and 
survival [23].
No significant differences were found between CTRL or REPL groups for any of the
measured parameters. The absence of a detectable difference between CTRL and REPL at 
P70 in both biochemical and molecular markers is likely due to VitC levels being restored at 
an earlier time point after repletion. We have recently reported that overall hippocampal 
volume was significantly reduced in prenatally deficient guinea pigs and persisted despite 
postnatal repletion [25]. This difference could be due to the hippocampal impairment 
occurring at a much earlier time-point (i.e. prenatally), as opposed to the currently presented 
data which investigates animals at postnatal day 70, thus much later than when the VitC
deficiency was initially imposed. However, we have recently investigated the effects of 
prolonged maternal VitC deficiency in neonate (P7) guinea offspring [33]. Brain VitC levels 
in the neonate VitC deficient pups were 60% lower than the control group but there was no 
difference in ascorbate oxidation ratio between deficient and control pups. No effect of 
maternal VitC deficiency on either MDA or F2-isoprostanes in brain tissue of of pups was 
found [33]. As the data is exclusively obtained in postnatal pups conclusions cannot be made
concerning a potential VitC deficiency induced increase in fetal oxidative stress. However,
the findings suggest that the increase in lipid oxidation and %DHA in the P70 guinea pigs 
included in the present study has occurred primarily as a result of postnatal deficiency.
In the brain, SVCT2 is the only known specific transporter that transports ASC into neurons
[37, 38]. Although mRNA expression of this transporter tended to increase in HP samples of 
the DEF group, the groups were not significantly different and this tendency was not 
confirmed by western blot. No significant differences in either gene or protein expression of 
7 
 
SVCT2 was found in BFC or BC samples in coherence with reports from studies in mice 
[20, 21]. Western blots with anti-SVCT2 showed double bands in all samples as has 
previously been reported [31, 32]. Decreasing the total protein load [39], on the gels did not 
resolve the problem. Previous studies reported a range from 50 kDa to 65kDa for SVCT2 in
western blots from various tissues and species, and this is attributed to variable glycosylation
and species specificity [39-42]. Although we did not find any significant changes in SVCT2 
protein expression, we cannot rule out the possibility of specific regional increases within the 
investigated brain areas. It can also be speculated that SVCT2 levels may have increased 
during perinatal life only to have dropped by P70. Differences in SVCT2 expression during 
pre- and postnatal life has been shown in mice documenting a developmental regulation of 
this transporter [20, 43]. However, no significant effect of postnatal VitC deficiency in 
Gulo(-/-) mice on SVCT2 expression in the brain was reported although a tendency of an 
upregulation of SVCT2 protein in cerebellum of VitC deficient pups was proposed, 
indicating a regional-specific SVCT2 regulation [20].
Our results are in accordance with dietary intervention studies of VitC deficiency in Gulo(-/-)
mice, in which low levels of VitC resulted in increase in oxidative stress markers [18, 34, 44].
However, in these studies maternal environment was protected by supplementing the Gulo(-/-)
dams to meet the demands of pregnancy. VitC deficiency was thus imposed postnatally to the 
newborn pups. Maternal environment of low VitC group in our present study is chronically 
low by gestational day 40 (data not shown) [33]. Thus, a consequence of a combined pre-
and postnatal VitC deficiency is assessed as well as the effect of re-introducing high levels of 
VitC immediately after birth.
VitC reaches the central nervous system through the choroid plexus, thus a differential 
regulation of the transporter particularly in this area remains a possibility. A study of regional 
brain ischemia in rats  showed loss of svct2 mRNA in the ischemic core followed by an 
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increase in the peri-infarct regions at 22h of reperfusion[45]. Similarly, the SVCT2 protein in 
brain was shown to increase on 2d and 5d following ischemia in mice and was also found to 
be increased around the ischemic core in areas where it would not usually be detected [46]. It 
should be noted, that the above studies have reported a difference in expression of this 
transporter two or five days after inducing ischemia, representing a short term effect as 
opposed to the chronic regime applied in our study.
Another possibility for not finding significant differences in brain SVCT2 expression 
corresponding to prolonged VitC deficiency would be because of tight regulation of the 
transporter and post-translational modifications. SVCT2 is supposedly glycosylated in-vivo  
to maintain its functionality [38] and mutations in glycosylation sites of human SVCT2 
significantly decreased VitC uptake in HepG2 cells [47]. Some in vitro studies have 
suggested that SVCT2 is regulated depending on the redox status of the cells showing an up-
regulation of the transporter in the presence of oxidants [32, 48]. Our findings propose that a
chronic low VitC level is indeed associated with an increase in lipid peroxidation but does
not increase SVCT2 in the measured brain regions. This could be due to variable stringency 
with which different factors can control the expression of SVCT2 in tissues.
CONCLUSIONS
In conclusion, chronic VitC deficiency during early life promoted postnatal redox imbalance 
in the brain, which was not observed in repleted animals. However, no association between 
dietary VitC and SVCT2 expression on either mRNA or protein level in the brain was 
observed. Our results suggest that modulation of SVCT2 expression within specific brain 
regions is not a potential mechanism to compensate for a chronic state of VitC deficiency in 
the brains of young guinea pigs.
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METHODS
Animal experimentation
The study was approved by Danish Animal Experimentation Inspectorate and in accordance 
with EU Directive 2010/63/EU for animal experiments. Animals were obtained as subsets in 
a large in vivo study [25]. Eighty pregnant Dunkin Hartley guinea pigs at gestation day 18 
(Charles Rivers Lab, Kieslegg, Germany) were equipped with subcutaneous (s.c.) microchips 
for identification (PET-CHIP ID, e.vet®, Danworth farm, West Sussex, UK), and randomized 
into weight stratified dietary groups receiving sufficient (900 mg, n=30) or deficient (100 mg, 
n=50) levels of VitC per kg diet (quality controlled diets by Special Diets Services, SDS, 
Witham, England). We have previously shown that the dose of 100 mg VitC/kg feed results 
in a non-scorbutic deficiency status in guinea pigs [24].  In this study, thirty female pups 
(n=30) were included, forming three dietary groups differing only in VitC content of the feed:
control (pre-/postnatally sufficient, CTRL, 900/750 mg vitC/kg diet), deficient (pre-
/postnatally deficient, DEF, 100/100 mg vitC/kg diet) or repleted (prenatally 
deficient/postnatally sufficient, REPL, 100/750 mg vitC/kg diet). The animals were housed in 
floor pens and allowed feed, hay and water ad libitum. They were weighed at least once a 
week. VitC status was verified by blood sampling (~ 300 µl) from v. saphena at its 
superficial course on tibia around postnatal day (P) 35 (data not shown). 
Euthanasia
Animals were anesthetized by inhalation with isoflurane (Isoba Vet 100%, Intervet 
International, Boxmeer, The Netherlands). After disappearance of voluntary reflexes 
(palpebral and interdigital), thoracotomy was performed and an intracardial blood sample was 
obtained using a 5 ml syringe and 18G-needle previously flushed with 15% tripotassium-
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EDTA. Animals were sacrificed by exsanguination and subsequent decapitation. Blood 
samples were immediately centrifuged and stabilized. Brains were excised and weighed 
before sectioning through the cerebral longitudinal fissure. One hemisphere (randomized 
left/right) was subsequently intended for biochemical, gene and protein expression analysis;
for gene and protein analysis HP, BC and BFC were isolated and snap-frozen in liquid 
nitrogen. Remaining brain tissue was frozen on dry ice for biochemical analysis. All the 
excised tissues were stored at -80°C until use. The paired hemisphere was stored for 
hippocampal volume assessment [25].
Biochemistry Analyses
Ascorbate and dehydroascorbic acid (DHA), the reduced and oxidized forms of VitC, 
respectively, in plasma and brain as well as malondialdehyde (MDA) and glutathione in brain 
were analyzed as described previously [26-28].
RNA extraction and RT-PCR 
RNA isolation was performed as described previously [29]. Briefly, approximately 25 mg of 
each of BC, BFC and HP tissues were homogenized in trizol (InVitrogen, Merelbeke, 
Belgium) and precipitated with chloroform (Sigma, Steinheim, Germany) and isopropanol 
(Merck, Darmstadt, Germany).The resulting RNA was purified using spin columns according 
to manufacturer’s instructions (SV Total RNA Isolation System, Promega, Madison, WI, 
USA) and was eluted with 50 µl nuclease free water. The purity of RNA was determined by 
spectrometry (Nanodrop 2000; Thermo Scientific, Wilmington, DE, USA) with absorbance 
ratios A260/A280 and A260/A230. RT-PCR was performed with 2 µg of RNA in duplicates 
yielding a total volume of 50 µl cDNA for each sample (MmLV RT enzyme, 5 x MmLV 
buffer and RNasin (Promega)); 10 mM dNTPs and Oligo (dT) primers (60 µg/120 µl) 
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(Fermentas GmbH, St Leon Roth, Germany); Random hexamer primer (2 µg/µl) (GE 
Healthcare, Uppsala, Sweden).  
Gene expression analysis
All cDNA samples were tested for DNA contamination with intron-spanning beta-actin
primers (Table 1) prior to real time quantitative PCR (Q-PCR) and only included if negative 
for contamination. PCR products of included genes were confirmed by electrophoresis in 2% 
agarose gel, followed by PCR clean-up (PCR Clean Up System; Promega,Sweden) and 
subsequent sequencing of PCR products (LGC genomics, Berlin, Germany).
For Q-PCR analysis, efficiency generated from specific standard curves was applied to each 
run. Q-PCR was conducted (SYBR Green I master LC480 and LC480, Roche, Basel, 
Switzerland) in 96-well white plates (Roche, Mannheim, Germany) with triplicates of all 
samples (in dilution 1:5), nuclease free water as negative control and calibrator as positive 
control. Target gene expression analysis of Svct2 [30] from the three different brain samples 
was done by normalizing to the reference gene, s18 (ribosomal protein S18). Primer 
sequences are displayed in Table 1.
Protein extraction and Western blot
Approximately 20 mg of brain tissue was homogenized in 250 µl ice cold radio-immuno-
precipitation assay (RIPA) buffer with protease inhibitors (150mM sodium chloride, 1 % 
Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50mM Tris, pH 8, 
1:100 sigma complete protease inhibitor cocktail) and centrifuged at  12000 rpm for 10 
minutes at 4°C. The resulting supernatant was transferred into aliquots and protein estimation 
was done using Bradford assay (Coomassie brilliant blue G-250 (Fluka, Damstadt, Germany), 
ethanol 96 % (Danish distillers, Roskilde, Denmark), phosphoric acid 85% (Merck), 1 mg/ml 
bovine albumin (Sigma) with brain lysates diluted in PBS (Dulbecco’s, pH 7.4) in triplicates 
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at 595 nm on a SpectraMax Plus 384 UV/VIS plate reader (Molecular Devices Inc., CA, 
USA).
Samples of approximately 30 µg of protein  diluted with loading buffer and sample reducing 
agent (Invitrogen NuPAGE 4X LDS sample buffer, Invitrogen NuPAGE 10X sample 
reducing agent) were heated at 70°C for 10 minutes and were loaded onto pre-cast 
polyacrylamide gels (Invitrogen NuPAGE 4-12% Bis-Tris gels). All samples were run in 
duplicates and electrophoresis proteins were transferred to PVDF membranes (GE Health 
Care, Sarl Fribourg, Switzerland) in a semi wet blot chamber (TE 77PWR, Amersham 
Biosciences) at 169 mA for 45 minutes. Membranes were blocked for 1 hour in 2 % blocking 
buffer (Amersham ECL Prime Blocking Agent) diluted in wash buffer (1XPBS and 0.1 %
Tween) and incubated with primary antibody, SVCT2 (1:200, anti-goat IgG, Sc-9926, Santa 
Cruz Biotechnology, CA, U.S) or Actin (1:20000, Mouse Anti Actin IgG1, Millipore,
Temecula, CA, U.S) in blocking buffer at 4°C overnight. Specificity of the antibody was 
tested by a pre-absorption test with blocking peptide for anti-SVCT2 (SC9926-P, Santa Cruz 
Biotechnology). After washing the membrane, following secondary antibody incubation in 2
% blocking buffer (1:4000, anti-goat IgG-HRP or 1:10,000, anti-mouse IgG-HRP, both from 
Santa Cruz Biotechnology) for one hour, the bands were visualized by enhanced 
chemiluminiscence (Amersham ECL Prime Western Blotting Reagent, UVP Biospectrum 
imaging system). Band location was identified by a western protein standard (Magic MarkTM
XP Western Protein Standard). Densitometry was performed with UVP Life Science Series 
Software. SVCT2 band intensities were initially normalized to respective actin bands. 
Normalization between blots was done to control sample that was also run in duplicates at the 
same position on all gels, as an internal control. SVCT2 expression was finally normalized 
relative to corresponding internal control.
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Statistics
Differences in biochemistry, mRNA and protein expression were analysed by using one-way 
ANOVA followed by Tukey’s multiple comparisons posthoc test in case of statistical 
significance. Variance homogeneity was analysed by Levine’s test for equal variance and 
data transformation was done when Levine’s test for equal variance was significant (p<0.05). 
All analyses were conducted using SAS/JMP version 8.0.
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Table 1 Primers for PCR and Q-PCR
Gene Primer Sequence Product size  (bp) NCBI Accession No.
Beta-actin (F): gtaaggacctctatgccaacaca
(R): atgccaatctcatctcgttttct
346 [GenBank:AF508792]
s18 (F): atgtggtgttgaggaaagcag
(R): gcttgttgtccagaccgttg
195 [GenBank:XM_003473925.1]
Svct2 (F): gtccatcggtgactacta
(R): atgccatcaagaacacagga
114 [GenBank:AF411585]
All primer sequences are presented in 5’-3’ direction (F): forward primer, (R): reverse 
primer. Sequence analysis confirmed the sequences similarity with the presented NCBI 
GenBank Accession numbers. 
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Table 2 Biochemical results from plasma and brain
Biochemistry results of CTRL, REPL and DEF guinea pigs from brain and plasma following 
a prenatal VitC deficiency and subsequent two months postnatal repletion or deficiency, 
compared to pre-and postnatally sufficient controls. Effect of VitC diet between three groups 
by one way ANOVA marked ***p<0.0001. All values are presented as means ± SD. Values 
with different superscript letters are significantly different.
CTRL REPL DEF Effect 
Plasma VitC (nmol/ml) 51.8 ± 22.4 a 57.3 ± 13.6 a 4.0 ± 3.2 b  ***
Plasma DHA%  (% of total VitC) 10.2 ± 4.9 a 7.7 ± 2.2 a 19.1 ± 3.8 b ***
Brain VitC (nmol/g tissue) 1399 ± 143 a 1498 ± 42 a 495 ± 252 b ***
Brain DHA% (% of total VitC) 4.5 ± 2.8 a 3.1 ± 2.2 a 9.5 ± 4.6 b ***
Brain MDA (nmol/g tissue) 313 ± 124 a 258 ± 58.9 a 476 ±106 b ***
Brain GSH (nmol/g tissue) 1348 ± 112 a 1407 ± 44.6 a 1341 ± 101.0 a
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Figure 1 Quantitative PCR analysis of Svct2 mRNA expression in brain.
Quantitative PCR analysis of svct2 from three brain regions of guinea pigs between CTRL, 
REPL and DEF groups ; Expressed values are mean of normalized ratio of svct2 to the 
reference gene s18 + SD ; target gene expression in HP (A), BC (B) and BFC (C), n=10 for 
each group. Effect of diet between the three groups was assessed by one way ANOVA 
(p>0.05).
Figure 2 Specificity of anti-SVCT2 in western blot.
(A) Specificity of anti-SVCT2 without pre-absorption of antibody with blocking peptide in 
guinea pig (Gp) brain lysates seen as a doublet above 60kDa and in mouse (M) brain lysates 
as a single band at 60 kDa; (B) Show brain lysates of Gp and M with pre-absorption of 
antibody with blocking peptide. Block arrow show the non-specific band detected in western 
blots from a few guinea pig brain lysates.
Western blot standard ladder (Std) and band lengths are displayed for both blots.
Figure 3 Western blot analysis of SVCT2 protein in brain.
Densitometry analysis of western blot analysis of SVCT2 protein levels from three brain 
regions of guinea pigs HP (A), BC (B) and BFC (C).; CTRL: control group, REPL: repleted 
group and DEF: deficient group. Values are displayed as mean of normalized ratio to actin +
SD.
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a b s t r a c t
Antioxidant defences are comparatively low during foetal development making the brain particularly
susceptible to oxidative stress during antioxidant deﬁciencies. The brain is one of the organs containing
the highest concentration of vitamin C (VitC) and VitC deﬁciency during foetal development may place
the brain at risk of redox status imbalance. In the present study, we investigated the developmental
pattern and effect of VitC deﬁciency on antioxidants, vitamin E and superoxide dismutase (SOD),
assessed oxidative damage by measuring malondialdehyde (MDA), hydroxynonenal (HNE) and nitrotyr-
osine (NT) and analysed gene and protein expression of apoptosis marker caspase-3 in the guinea pig
foetal brain at two gestational (GD) time points, GD 45/pre-term and GD 56/near term following either
a VitC sufﬁcient (CTRL) or deﬁcient (DEF) maternal dietary regime. We show that except for SOD,
antioxidants and oxidative damage markers are differentially expressed between the two GDs, with high
VitC (po0.0001), NT modiﬁed proteins (po0.0001) and active caspase-3 levels (po0.05) at pre-term
and high vitamin E levels (po0.0001), HNE (po0.0001) and MDA (po0.0001) at near term. VitC
deﬁciency signiﬁcantly increased SOD activity (po0.0001) compared to CTRLs at both GDs indicating a
compensatory response, however, low levels of VitC signiﬁcantly elevated MDA levels (po0.05) in DEF at
near term. Our results show a differential regulation of the investigated markers during late gestation
and suggest that immature brains are susceptible to oxidative stress due to prenatal vitC deﬁciency in
spite of an induction of protective adaptation mechanisms.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
The developing brain has a high metabolic activity making it
vulnerable to oxidizing agents such as free radicals [55], a situation
that is further exacerbated by a yet immature scavenging anti-
oxidant system in early life [33,48]. Although antioxidant defence-
mechanisms in guinea pig brains during foetal development have
been investigated [36], the manifestation of macromolecular
modiﬁcations due to lipid peroxidation or by similar oxidizing
agents and cell death in the near term brain is unknown. It is also
not known if the pertinent oxidative changes during development
are likely to increase in the brain when deprived of optimal
antioxidant levels.
Guinea pigs are precocial rodents with a gestation length of
approximately 66 days with the peak of exponential brain growth
(‘the brain growth spurt’) being reached about 15 days before birth
(i.e. around gestation day (GD) 50) [12]. Interference with optimal
requirements for the foetus may impose several negative effects
on developmental outcome such as lower body weight [11] and in
the brain lead to reduction of cells in hippocampal morphogenesis
[4] and cognitive alterations as observed in rats [38]. Oxidative
stress caused by deﬁciency in antioxidants like glutathione in the
developing brain has been shown to negatively affect mitochon-
dria [21] and also to result in an age-dependent neurodegenera-
tion in the hippocampus [1].
Activity of antioxidant enzymes in guinea pigs such as super-
oxide dismutase, catalase, glutathione peroxidase (GPx) and glu-
tathione reductase have been demonstrated to remain constant
from GD 30 to 45 and to increase from GD 45 to GD 60, with the
exception of superoxide dismutase (SOD) that remained constant
throughout the GD 30–60 period [36]. In rats, postnatal GPx
activity in the brain has been found to remain constant from birth
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whereas the activity of cytoplasmic SOD increases from birth until
60 days after birth in rats [34]. Analysis of antioxidant protein
levels in developing mice brains from embryonic day 18 to
postnatal day 21 has shown that total SOD activity, catalase and
GPx activity increases suggesting an increase in antioxidants in
perinatal and neonatal brains relative to foetal development [25].
Thus, despite inter-species differences and differences in degree of
postnatal development (i.e. altrician vs. precocial species), there
seems to be a general trend of increasing antioxidant capacity in
the brain during the course of development. Hence, a decrease
in antioxidant capacity could potentially disturb the redox
homeostasis in the brain leading to negative consequences on
development.
Vitamin C (VitC) deﬁciency in humans has been associated with
increases in premature births and predisposing newborns’ to
oxidative stress [39,44]. VitC is one of the primary antioxidants
in the brain and selectively accumulates in high amounts also
during foetal development [14,26,33]. Interruption of vitC trans-
port to the brain in the svct2�/� mouse is detrimental to
perinatal survival [13,50], underlining the pivotal role of vitC in
the developing central nervous system. Due to its one electron
reduction potential, VitC effectively inhibits lipid peroxidation and
scavenges several reactive oxidizing compounds such as super-
oxide, hydrogen peroxide and hydroxyl radicals as well as enabling
the recycling of other antioxidant compounds such as vitamin E
[7,20,30,49]. In guinea pigs, VitC deﬁciency during both pre- and
postnatal development has been linked to deviations in hippo-
campal development [51,52]. Alteration of apoptotic mechanisms
due to redox imbalance in the foetal brain has also been reported
in several studies, however, the underlying mechanism and
potential cause vs consequence remains to be disclosed [19,43].
Like humans, guinea pigs cannot synthesize VitC due to a non-
functional gulonolactone oxidase (Gulo) gene [40] and therefore
rely on an adequate dietary supply. The present study investigated
the developmental course of and potential effects of VitC deﬁ-
ciency on markers of antioxidants, redox imbalance and apoptosis
signalling in foetal guinea pig brains at two different gestational
time points at which brain growth is at a peak, GD 45/pre-term
and GD 56/near term.
Materials and methods
Animal experiment
The animal study adheres to the guidelines of EU Directive
2010/63/EU and was approved by Danish Animal Experimentation
Inspectorate. Twenty pregnant guinea pigs between GD 6–10 were
obtained from Charles Rivers Lab, Kieslegg, Germany. The animals
were microchipped subcutaneously (PET-CHIP ID, Danworth farm,
West Sussex, UK) and randomized according to GD and body
weight into two groups receiving diets only differing in VitC
content (specialized diets sniff, GmbH), Control: CTRL (900 mg/
kg diet, n¼10) and Deﬁcient: DEF (100 mg/kg diet, n¼10). It has
previously been shown by us that the 100 mg VitC diet in guinea
pigs results in non-scorbutic VitC deﬁciency [32,53]. Each of the
groups was further randomized to having caesarian section
(followed by euthanasia) performed at GD 45 or GD 56. The
animals were housed in ﬂoor pens with straw bedding and feed,
hay and water were provided ad libitum. They were weighed once
every week and blood was sampled (�300 ml) once in every two
weeks from v. saphena at its superﬁcial course on tibia to verify
VitC status (data not shown).
At euthanasia three dams, one from CTRL group and two from DEF
group were found not to have conceived. Necropsy revealed no signs
of underlying disease and the animals were excluded from the study.
Euthanasia
Caesarean section was conducted on dams at GD 45 or GD 56.
Ten to ﬁfteen minutes prior to anaesthesia, dams were injected
with 2 mg/kg body weight Torbugesic (10 mg/ml butorphanol,
Scan Vet Animal Health, Fredensborg, Denmark) subcutaneously
to achieve analgesia. Anaesthesia was achieved by inhalation of
isoﬂurane (Isoba Vet 100%, Intervet International, Boxmeer, The
Netherlands). After the disappearance of voluntary reﬂexes (inter-
digital and skin-pinch), caesarean was performed by laparotomy
through linea alba exposing the uterus. Excision of fetuses was
done one at a time starting from the apex of the left horn towards
the basis and subsequently commencing at the apex of the right
horn. Immediately following delivery of each pup, the body weight
was recorded, an intracardial blood sample was taken and the pup
was euthanized by decapitation, the procedure lasting no more
than 2 minutes. In the event of a pup displaying reﬂexes,
euthanization by intraperitoneal injection of 0.5 ml pentobarbital
(200 mg/ml) supplemented with lidocaine (Veterinary Pharmacy,
University of Copenhagen, Denmark) was performed. Gender was
recorded and post mortem autopsy with tissue sampling was
performed on each pup, tissues allocated either to ﬁxative or
frozen for later analysis. Blood samples were centrifuged, stabi-
lized and frozen after the intracardial blood sampling of the ﬁnal
pup from each dam. Once all the pups were removed from the
uterus, thoracotomy of the damwas performed and an intracardial
blood sample was taken before sacriﬁcing by decapitation and
exsanguination.
The brain was removed and the left hemisphere frozen in liquid
nitrogen and the right hemisphere ﬁxated in 4% PFA (paraformal-
dehyde in phosphate buffered saline, 0.15 M, pH 7.5) for 48 h then
transferred to 1%PFA for long term storage.
All frozen tissues were stored at �80 1C until further analysis.
For the current study all foetal left brain hemispheres from a total
of 85 fetuses, were blocked for gender and body weight and
randomized to be used for gene and protein expression analysis
(N values; 12 CTRL/GD 45, 9 DEF/GD 45, 10 CTRL/GD 56, 11 DEF/GD
56) or biochemistry (N Values; 12 CTRL/GD 45, 10 DEF/GD 45, 10
CTRL/GD 56, 11 DEF/GD 56).
Biochemistry
Analysis of VitC and malondialdehyde (MDA) in brain were
performed as described previously [28,29,31]. Brieﬂy, tissue
samples (app. 0.5 g) were homogenized in PBS, centrifuged at
16,000� g for 1 min at 4 1C. For VitC analysis, an aliquot was
stabilized with an equal volume of 10% meta-phosphoric acid
containing 2 mM EDTA (Merck, Whitehouse Station, NJ, USA),
centrifuged, and the supernatant analysed by high-performance
liquid chromatography (HPLC) with colorimetric detection. Levels
of MDA were assessed by thiobarbituric acid derivatization fol-
lowed by speciﬁc quantiﬁcation of the genuine MDA(TBA)2 adduct
by HPLC with ﬂuorescence detection.
Analysis of α-tocopherol and γ-tocopherol was performed by HPLC
with coulometric detection as modiﬁed from Sattler et al. [46]. Brieﬂy,
to 100 ml of tissue homogenate was added 25 ml freshly prepared
2,6-di-tert-butyl-p-cresol (10 mg/ml; Sigma, Copenhagen, Denmark),
100 ml sodium dodecyl sulphate (29 mg/ml, Sigma), 800 ml H2O, 900 ml
ethanol and 100 ml 2-propanol. The cold mixture was extracted with
1 ml of n-hexane (Merck, Damstadt, Germany) of which 500 ml of
organic phase was reduced to dryness at 40 1C using an airstream and
subsequently redissolved in 100 ml ethanol for 2 min using a vortex
mixer. Following centrifugation, 20 ml of the supernatant was used for
HPLC analysis. Superoxide dismutase activity (SOD) was analysed
using the Ransod colorimetric assay (SD125, Randox Laboratories
Limited, UK) on tissue lysates according to manufacturer’s instructions.
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RNA extraction and RT-PCR
Approximately 25 mg of each of brain tissues was homogenized
in trizol (InVitrogen, Merelbeke, Belgium) and precipitated with
chloroform (Sigma Aldrich, Steinheim, Germany) and isopropanol
(Merck, Darmstadt, Germany). Puriﬁed RNA (SV Total RNA Isola-
tion System, Promega, Madison, WI, USA) was eluted with 50 ml
nuclease free water and the purity of RNA was determined by
absorbance ratios A260/A280 and A260/A230 (Nanodrop 2000;
Thermo Scientiﬁc, Wilmington, DE, USA). cDNA synthesis was
performed by RT-PCR with 2 mg of RNA (MmLV RT enzyme,
5�MmLV buffer and RNasin (Promega)); 10 mM dNTPs and Oligo
(dT) primers (60 mg/120 ml) (Fermentas GmbH, St Leon Roth,
Germany); Random hexamer primer (2 mg/ml) (GE Healthcare,
Uppsala, Sweden).
Gene expression analysis
Intron-spanning beta-actin primers were used on all cDNA
(Table 1) prior to real time quantitative PCR (Q-PCR) to test for
genomic contamination. None of the included samples displayed
signs of contamination. PCR products of included genes were
run on 2% agarose gels to conﬁrm the product size and were
then puriﬁed by PCR clean-up (PCR Clean Up System; Promega,
Sweden) and subsequently submitted for sequencing (LGC geno-
mics, Berlin, Germany) to conﬁrm speciﬁcity.
Q-PCR was conducted (SYBR Green I master LC480 and LC480,
Roche, Basel, Switzerland) in 96-well white plates (Roche, Man-
nheim, Germany) with all samples in triplicates (in dilution 1:5),
nuclease free water as negative control and calibrator as positive
control. Gene expression analysis of Caspase 3 from brain samples
was normalized to the reference gene, s18 (ribosomal protein S18).
Primers are listed in Table 1.
Protein extraction and Western blot
Protein was extracted from brain tissue with radio-immuno-
precipitation assay buffer (RIPA: 150 mM sodium chloride, 1%
Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulphate, 50 mM Tris, pH 8) with 1:100 protease inhibitors (Sigma
complete protease inhibitor cocktail). Estimation of protein was
done by bicinchoninic acid assay (Calbiochem Novagen BCA
Protein Assay kit), according to the manufacturer’s protocol, in
triplicates at 562 nm on a SpectraMax Plus 384 UV/VIS plate
reader (Molecular Devices Inc., CA, USA).
Approximately 100 mg of protein diluted with reducing agent
and loading buffers (Invitrogen NuPAGE 4X LDS sample buffer,
Invitrogen NuPAGE 10X sample reducing agent) were heated at
70 1C for 10 min before loading on precast gels (Invitrogen NuPAGE
4–12% Bis-Tris gels) in duplicates together with an internal
standard comprising equal volumes of all samples. Gel to PVDF
membrane transfer of protein was performed in a semi dry
transfer unit (TE 77PWR, Amersham Biosciences) prior to 1 h
blocking in 2% blocking buffer (Amersham ECL Prime Blocking
Agent in PBS-T wash buffer,1XPBS and 0.1% Tween) before incuba-
tion with cleaved anti-caspase-3 (9661, Cell Signaling Technology,
Danvers, MA, USA) or 4% blocking buffer before incubation with
anti-nitrotyrosine (anti-NT, 06-284, Millipore, Temecula, CA)
or anti-4-hydroxynonenal (anti-HNE, HNE 11-S, Alpha Diagnostic
International, San Antonio, TX, USA). Antibody speciﬁcity of
cleaved caspase-3 was tested by pre-absorption with equal volume
of the blocking peptide (#1050, Cell Signaling Technology,
Danvers, MA, USA) and speciﬁcity of anti-nitrotyrosine was tested
by pre-absorption of 0.5 mg/ml primary antibody with 15 mM free
NT (#89540, Cayman Chemical, Ann Arbor, MI, USA) with respec-
tive controls (#9663 Caspase-3 control Cell signalling technology,
Danver, MA, USA); (#12–354, NT immunoblotting control, Chemi-
con, Temecula, CA, USA). Membranes were incubated with primary
antibody overnight at 4 1C (1:1000, cleaved caspase-3 or 0.5 mg/ml
anti-NT or 1:2000 anti-HNE), followed by secondary antibody
(anti-rabbit IgG-HRP, 7074, Cell Signaling Technology, Danvers,
MA, USA) 1: 1000, 1:6000 and 1:2000 for anti-caspase-3, anti-NT
and anti-HNE proteins respectively. Imaging was achieved by
enhanced chemiluminiscence (Amersham ECL Prime Western
Blotting Reagent, UVP Biospectrum imaging system). Band-sizes
were identiﬁed by Western blot protein standard (Magic MarkTM
XP Western Protein Standard). Cleaved caspase-3 bands were
located by an additional protein standard (ECL DualVue Western
Blotting Markers, RPN810, Amersham Biosciences) with a speciﬁc
secondary antibody (1:10000, HRP-S) diluted together with the
secondary antibody. The NT and HNE blots were stripped with
0.5 M sodium hydroxide (Merck, Darmstad, Germany) before
re-probing with loading control (mouse anti-actin, 1:20000, MAB
1501, Millipore, Temecula, CA, USA). Target bands of cleaved
caspase-3 or lanes in case of NT and HNE blots were normalized
to the loading control, detected by anti-mouse IgG-HRP secondary
antibody (1:10000, SC-2005, Santa Cruz Biotechnology, CA, USA).
UVP Life Science Series Image Acquisition and Analysis software
was used for densitometry and blots were normalized to an
internal control.
Statistics
SAS/JMP statistical version 8.0 was used to analyse all data.
Analysis of Q-PCR expression data was performed by Student’s
t-test. Two-way ANOVA was used to analyse biochemistry and
Western blot densitometry. Interaction between factors, diet and
GD, was reported together with main effects when statistically
signiﬁcant (po0.05) followed by Tukeys HSD posthoc comparisons.
Results
Brain antioxidant status
As shown in Table 2, VitC concentration in the brain was
signiﬁcantly higher in the CTRL groups of both gestational days
compared to DEF counterparts (po0.0001). Two-way ANOVA
showed effects of both diet and GD (po0.0001) on VitC levels as
well as an interaction between diet and GD (po0.0001). A decrease
of approximately 20% in VitC was observed in CTRL GD 56 relative to
GD 45 (po0.0001).This was not found in the DEF group, where VitC
levels did not differ between gestational dates. In contrast to total
VitC in the brain, α-tocopherol levels were high on GD 56 relative to
GD 45 (po0.0001) with no signiﬁcant effect of diet. Conversely, two-
way ANOVA showed a signiﬁcant effect of diet on γ-tocopherol
(po0.05), the DEF-group displaying overall increased levels. How-
ever, tocopherols were not signiﬁcantly different between CTRL and
Table 1
Primer sequences applied in the gene expression analysis.
Gene Primer sequence Product size (bp) NCBI accession no.
Beta-
actin
(F): gtaaggacctctatgccaacaca 346 AF508792
(R): atgccaatctcatctcgttttct
s18 (F): atgtggtgttgaggaaagcag 195 XM_003473925.1
(R): gcttgttgtccagaccgttg
Caspase-3 (F): ctggaatggcacctcgactt 315 XM_003469171.1
(R): ccccggcaagcctgaataat
Sequences are presented in the 50–30 direction (F): forward, (R): reverse.
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DEF groups at the individual time-points. SOD was signiﬁcantly
increased by VitC deﬁciency (po0.0001) but was not affected by GD.
Brain oxidative damage
Western blot of HNE modiﬁed proteins ranged between 20 and
120 kDa in guinea pig brain lysates (data not shown). Two-way
ANOVA of densitometry data showed that the intensity of HNE
modiﬁcations at GD 56 was twice as high as GD 45 with a
signiﬁcant effect of GD (po0.0001) (Fig. 1A). However, no sig-
niﬁcant differences were found between CTRL and DEF groups at
either gestational day. MDAwas measured in brain homogenate as
a marker of lipid oxidation. Two-way ANOVA showed signiﬁcant
effects of both diet (po0.001) and gestational age (po0.0001).
In agreement with the anti-HNE densitometry data, MDA was
signiﬁcantly elevated at GD 56 compared to 45 for both dietary
regimens separately (po0.0001). Moreover, VitC deﬁciency
resulted in increased brain MDA compared to controls at GD 56
(po0.05) but at GD45, the increase did not reach statistical
signiﬁcance (Fig. 1B).
NT modiﬁed proteins were detected by Western blotting
between 35 and 15 kDa in brain lysates. Pre-absorption of primary
antibody with free NT abolished all the bands in guinea pig brain
lysate and almost all bands in the positive control conﬁrming
speciﬁcity of the antibody (data not shown). A signiﬁcant main
effect of GD (po0.0001) was detected with highest levels of NT
modiﬁed proteins in GD 45 brains (Fig. 1C). There was no
detectable effect of diet on the level of NT modiﬁed proteins at
either gestational day.
Caspase-3 expression
Q-PCR analysis of caspase-3 gene-expression in the brain
was not signiﬁcantly different between CTRL and DEF groups in
either gestational day (Fig. 2A). Cleaved caspase-3 Western blot-
ting showed a single band just below 15 kDa. Pre-absorption of
primary antibody with blocking peptide abolished the speciﬁc
bands from guinea pig brain lysate and the positive control
conﬁrming the speciﬁcity of the antibody (data not shown).
Two-way ANOVA of densitometry data showed that GD had a
signiﬁcant effect on cleaved caspase-3 (po0.05) with higher levels
at GD 45 compared to GD 56 (Fig. 2B). Densitometry analysis
at either gestational day did not show signiﬁcant differences
between CTRL and DEF groups (Fig. 2B).
Discussion
In the present study, we show that immature brains are suscep-
tible to oxidative stress in spite of an induction of protective
adaptation mechanisms. Oxidative stress and damage markers in
guinea pig cerebral cortex were assessed at preterm and near term
gestational time points with and without maternal VitC deﬁciency as
a potential oxidative insult.
Brain VitC levels in DEF groups were signiﬁcantly lower than
CTRL as expected, and while VitC levels in the DEF group remained
similar at the two gestational days, VitC in GD 56 CTRL was
signiﬁcantly lower than GD 45 CTRL. This ﬁnding indicates a
developmental requirement of increased VitC during the preterm
period possibly as a response to lower protective mechanisms
against oxidizing agents as has previously been suggested [36].
However, in contrast to CTRLs, the DEF group did not display a
near-term drop in concentration but rather showed retention of
VitC, possibly to avoid any further loss than the already existing
low level. The decrease in VitC toward term in CTRL animals
is in line with ﬁndings in humans reporting a late gestation
decrease of VitC in all foetal tissues including the brain [58,59].
This decrease in the brain has been suggested to be due to growth
Table 2
Brain antioxidant status in prenatally VitC deﬁcient and control guinea pigs at GD 45 and GD 56.
CTRL GD 45 CTRL GD 56 DEF GD 45 DEF GD 56 Effect of VitC Effect of GD
VitC (nmol/g tissue) 30437285a 23517137b 10167270c 9667242c nnn nnn
α-Tocopherol (nmol/g tissue) 5.570.8b 9.071.0a 4.671.0b 9.471.5a NS nnn
γ-Tocopherol (nmol/g tissue) 0.5270.46 0.5070.36 0.8070.5 0.8970.39 n NS
Superoxide dismutase (U/g tissue) 9072a 9272a 13373b 13774b nnn NS
CTRL: controls; DEF: deﬁcient. GD: gestational day. Values are presented as means7SD. Differences between groups were assessed using two-way ANOVA with diet and GD
as factors followed by Tukeys HSD test for individual comparisons. NS: not signiﬁcant. Different superscript letters indicate that groups are signiﬁcantly different.
npo0.05.
nnpo0.001.
nnnpo0.0001.
Fig. 1. Oxidative damage in foetal guinea pig brains. Markers of increased oxidation and suggestive oxidative damage in the brain of guinea pigs subjected to prenatal vitC
deﬁciency (DEF) (dark bars) or control diet (CTRL) (light bars) during development. Foetuses were excised by caesarean section at GD 45 and GD 56. (A) Densitometric
analysis of HNE modiﬁed proteins in brain homogenate; results are normalized to actin; (B) Malondialdehyde in brain homogenate, measured by HPLC; (C). Densitometric
analysis of nitrotyrosine modiﬁed proteins normalized to actin. Data are expressed as means7SD. npo0.05; nnnpo0.0001 by ANOVA.
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and maturation of non-neuronal cells and maturation and myelina-
tion of neurones [16,59]. Recent studies by us have shown that a pre-
natal low VitC causes a reduction in foetal body and brain weight at
GD 45 but not at GD 56 (unpublished results), indicating that a
developing foetus is able to compensate for a pre-imposed negative
effect of VitC deﬁciency during the ﬁnal weeks of gestation.
Our α-tocopherol data implies that it increases with progres-
sion in development during late gestation. Interaction between
cytosolic VitC and membrane bound vitamin E regenerates oxi-
dized vitamin E and results in an efﬁcient antioxidant mechanism
[9], which suggests that VitC deﬁciency may alter vitamin E levels
hereby possibly disrupting membrane integrity. Some in-vivo
studies have shown that intake of high VitC results in an increased
vitamin E in tissues [5,17,18]. This was not the case when
evaluating α-tocopherol in CTRL vs. DEF groups of this study,
however, VitC showed a main effect on γ-tocopherol levels in the
brain. γ-Tocopherol has been associated with anti-inﬂammatory
properties, decreased superoxide anion generation and inhibition
of lipid peroxidation, hereby reducing adverse effects of oxidative
imbalance [23,45]. Our present ﬁndings suggest an increase in
γ-tocopherol in response to VitC deﬁciency, whereas levels during
late gestational progression were relatively constant in both CTRL
and DEF groups.
In the current study, VitC deﬁciency increased SOD activity
during late gestation. SOD activity in CTRL groups at both GD is in
agreement with a previous report of constant SOD levels in guinea
pig foetal brains throughout gestation from GD 30 to GD 60 [36].
As a consequence of low VitC levels, increases in SOD activity in
DEF compared to CTRLs at both GD indicates foetal ability to
induce a compensatory mechanism, likely due to increased pro-
duction of superoxide radicals [24]. Various studies have reported
an increase in SOD activity in the brain as an adaptive mechanism
to tolerate oxidative damage in neurodegenerative conditions [41],
stress [10] and oxidant induced neurotoxicity [6]. Studies like these
with additional assessment of antioxidants like catalase, glutathione
peroxidase or oxidative damage markers helps in understanding
whether such adaptive mechanisms are able to preserve the redox
status [3,57].
HNE modiﬁed proteins, which indicate oxidative damage due
to lipid peroxidation, were signiﬁcantly high at GD 56, regardless
of VitC status, likely due to the increase in poly-unsaturated fatty
acids in the brain at near term. An increased susceptibility of lipid
peroxidation in near term brains of guinea pigs has previously
been reported [37]. Although HNE modiﬁed proteins were not
signiﬁcantly different between CTRL and DEF, a trend similar to the
obtained MDA levels was observed between the two GD, with
signiﬁcantly higher MDA levels at near term further supporting
the maturational related increase of lipid peroxidation in the brain
as reported by others in guinea pigs brain [37]. Signiﬁcant increase
of MDA levels in DEF at GD 56 and not in DEF at GD45 compared to
their CTRL suggests that compensatory mechanisms that may have
been present at earlier gestation may not be enough to protect
from lipid peroxidation due to low levels of VitC in the brain.
Earlier studies by us and others have shown a similar inverse
relation of VitC levels to lipid peroxidation in the brain [15,33] and
the vital role of ascorbate has previously been demonstrated to
inhibit lipid peroxidation in rat brain microsomes [47]. Conversely,
no signiﬁcant differences in NT modiﬁed proteins between CTRL
and DEF suggests that posttranslational modiﬁcation of proteins
by NT is not effected by VitC deﬁciency and instead, as proposed
by others, NT may be involved in mediating cell signalling at its
basal levels during development [27,35].
Results from oxidative stress based in-vivo studies have sug-
gested an increased free radical production or decreased antiox-
idant mechanisms in the immature brain [36,56], which in turn
may initiate cellular events to initiate mechanisms of apoptosis
[8,42] like caspase-3 activation [22]. Our ﬁnding of high levels
of cleaved caspase-3 in GD 45 compared to GD 56 indicates a
developmental phenomenon in agreement with what has been
shown by others [2], placing cleaved caspase-3 as playing an
important role in reducing neuronal overproduction in the devel-
oping brain [54]. The guinea pig is a precocial species and neuronal
number relative to adult stage are achieved by GD 48 [12]. Hence,
although a gestational effect was seen for cleaved caspase-3, the
difference was small implying that most of the cell death asso-
ciated with development is likely to have occurred before the
investigated time-points. No signiﬁcant differences in caspase-3
gene expression or cleaved caspase-3 protein levels between CTRL
and DEF groups at any of the GDs indicates that VitC deﬁciency
does not modulate caspase-3 mediated apoptosis and may not be
the underlying mechanism associated with hippocampal impair-
ment observed in our earlier ﬁndings [51,52].
Conclusion
Guinea pig foetal brains have differential requirements of
antioxidants with high VitC levels at pre-term, a higher require-
ment of α-tocopherol at near term and constant SOD activity.
Oxidative NT modiﬁcations and active caspase-3 levels are higher
at pre-term and are prone to increased lipid peroxidation at near
Fig. 2. Expression analysis of caspase-3 in the brain. (A) Quantitative PCR analysis
of caspase-3 in guinea pig foetal brains comparing vitC deﬁcient (dark bars) to
controls (light bars) on two gestational times points (GD45 and 56). Expressed
values are normalized to the reference gene s18 and displayed as mean7SD.
(B) Densitometric analysis of levels of cleaved caspase-3 obtained by Western blot
and normalized to actin levels. Data are expressed as means7SD. npo0.05
by ANOVA.
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term signifying differential expression of oxidative damage mar-
kers associated with brain maturity. Prenatal VitC deﬁciency in the
guinea pig foetal brain does not modulate levels of vitamin E, NT
or HNE protein modiﬁcations or caspase-3 however, increases SOD
activity as compensation although this is not adequate to prevent
increased lipid peroxidation at the investigated time points.
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